192 results on '"M. Wrigley"'
Search Results
2. Multi-point Regression Voting for Shape Model Matching.
- Author
-
Paul A. Bromiley, Claudia Lindner 0001, Jessie Thomson, M. Wrigley, and Timothy F. Cootes
- Published
- 2016
- Full Text
- View/download PDF
3. Impact of diabetes on the management and outcomes in atrial fibrillation:an analysis from the ESC-EHRA EORP-AF Long-Term General Registry
- Author
-
Wern Yew Ding, Agnieszka Kotalczyk, Giuseppe Boriani, Francisco Marin, Carina Blomström-Lundqvist, Tatjana S. Potpara, Laurent Fauchier, Gregory.Y.H. Lip, G. Boriani, G.Y.H. Lip, L. Tavazzi, A.P. Maggioni, G.-A. Dan, T. Potpara, M. Nabauer, F. Marin, Z. Kalarus, A. Goda, G. Mairesse, T. Shalganov, L. Antoniades, M. Taborsky, S. Riahi, P. Muda, I. García Bolao, O. Piot, K. Etsadashvili, E. Simantirakis, M. Haim, A. Azhari, J. Najafian, M. Santini, E. Mirrakhimov, K.A. Kulzida, A. Erglis, L. Poposka, M. Burg, H. Crijns, Ö. Erküner, D. Atar, R. Lenarczyk, M. Martins Oliveira, D. Shah, E. Serdechnaya, E. Diker, D. Lane, E. Zëra, U. Ekmekçiu, V. Paparisto, M. Tase, H. Gjergo, J. Dragoti, M. Ciutea, N. Ahadi, Z. el Husseini, M. Raepers, J. Leroy, P. Haushan, A. Jourdan, C. Lepiece, L. Desteghe, J. Vijgen, P. Koopman, G. Van Genechten, H. Heidbuchel, T. Boussy, M. De Coninck, H. Van Eeckhoutte, N. Bouckaert, A. Friart, J. Boreux, C. Arend, P. Evrard, L. Stefan, E. Hoffer, J. Herzet, M. Massoz, C. Celentano, M. Sprynger, L. Pierard, P. Melon, B. Van Hauwaert, C. Kuppens, D. Faes, D. Van Lier, A. Van Dorpe, A. Gerardy, O. Deceuninck, O. Xhaet, F. Dormal, E. Ballant, D. Blommaert, D. Yakova, M. Hristov, T. Yncheva, N. Stancheva, S. Tisheva, M. Tokmakova, F. Nikolov, D. Gencheva, B. Kunev, M. Stoyanov, D. Marchov, V. Gelev, V. Traykov, A. Kisheva, H. Tsvyatkov, R. Shtereva, S. Bakalska-Georgieva, S. Slavcheva, Y. Yotov, M. Kubíčková, A. Marni Joensen, A. Gammelmark, L. Hvilsted Rasmussen, P. Dinesen, S. Krogh Venø, B. Sorensen, A. Korsgaard, K. Andersen, C. Fragtrup Hellum, A. Svenningsen, O. Nyvad, P. Wiggers, O. May, A. Aarup, B. Graversen, L. Jensen, M. Andersen, M. Svejgaard, S. Vester, S. Hansen, V. Lynggaard, M. Ciudad, R. Vettus, A. Maestre, S. Castaño, S. Cheggour, J. Poulard, V. Mouquet, S. Leparrée, J. Bouet, J. Taieb, A. Doucy, H. Duquenne, A. Furber, J. Dupuis, J. Rautureau, M. Font, P. Damiano, M. Lacrimini, J. Abalea, S. Boismal, T. Menez, J. Mansourati, G. Range, H. Gorka, C. Laure, C. Vassalière, N. Elbaz, N. Lellouche, K. Djouadi, F. Roubille, D. Dietz, J. Davy, M. Granier, P. Winum, C. Leperchois-Jacquey, H. Kassim, E. Marijon, J. Le Heuzey, J. Fedida, C. Maupain, C. Himbert, E. Gandjbakhch, F. Hidden-Lucet, G. Duthoit, N. Badenco, T. Chastre, X. Waintraub, M. Oudihat, J. Lacoste, C. Stephan, H. Bader, N. Delarche, L. Giry, D. Arnaud, C. Lopez, F. Boury, I. Brunello, M. Lefèvre, R. Mingam, M. Haissaguerre, M. Le Bidan, D. Pavin, V. Le Moal, C. Leclercq, T. Beitar, I. Martel, A. Schmid, N. Sadki, C. Romeyer-Bouchard, A. Da Costa, I. Arnault, M. Boyer, C. Piat, N. Lozance, S. Nastevska, A. Doneva, B. Fortomaroska Milevska, B. Sheshoski, K. Petroska, N. Taneska, N. Bakrecheski, K. Lazarovska, S. Jovevska, V. Ristovski, A. Antovski, E. Lazarova, I. Kotlar, J. Taleski, S. Kedev, N. Zlatanovik, S. Jordanova, T. Bajraktarova Proseva, S. Doncovska, D. Maisuradze, A. Esakia, E. Sagirashvili, K. Lartsuliani, N. Natelashvili, N. Gumberidze, R. Gvenetadze, N. Gotonelia, N. Kuridze, G. Papiashvili, I. Menabde, S. Glöggler, A. Napp, C. Lebherz, H. Romero, K. Schmitz, M. Berger, M. Zink, S. Köster, J. Sachse, E. Vonderhagen, G. Soiron, K. Mischke, R. Reith, M. Schneider, W. Rieker, D. Boscher, A. Taschareck, A. Beer, D. Oster, O. Ritter, J. Adamczewski, S. Walter, A. Frommhold, E. Luckner, J. Richter, M. Schellner, S. Landgraf, S. Bartholome, R. Naumann, J. Schoeler, D. Westermeier, F. William, K. Wilhelm, M. Maerkl, R. Oekinghaus, M. Denart, M. Kriete, U. Tebbe, T. Scheibner, M. Gruber, A. Gerlach, C. Beckendorf, L. Anneken, M. Arnold, S. Lengerer, Z. Bal, C. Uecker, H. Förtsch, S. Fechner, V. Mages, E. Martens, H. Methe, T. Schmidt, B. Schaeffer, B. Hoffmann, J. Moser, K. Heitmann, S. Willems, C. Klaus, I. Lange, M. Durak, E. Esen, F. Mibach, H. Mibach, A. Utech, M. Gabelmann, R. Stumm, V. Ländle, C. Gartner, C. Goerg, N. Kaul, S. Messer, D. Burkhardt, C. Sander, R. Orthen, S. Kaes, A. Baumer, F. Dodos, A. Barth, G. Schaeffer, J. Gaertner, J. Winkler, A. Fahrig, J. Aring, I. Wenzel, S. Steiner, A. Kliesch, E. Kratz, K. Winter, P. Schneider, A. Haag, I. Mutscher, R. Bosch, J. Taggeselle, S. Meixner, A. Schnabel, A. Shamalla, H. Hötz, A. Korinth, C. Rheinert, G. Mehltretter, B. Schön, N. Schön, A. Starflinger, E. Englmann, G. Baytok, T. Laschinger, G. Ritscher, A. Gerth, D. Dechering, L. Eckardt, M. Kuhlmann, N. Proskynitopoulos, J. Brunn, K. Foth, C. Axthelm, H. Hohensee, K. Eberhard, S. Turbanisch, N. Hassler, A. Koestler, G. Stenzel, D. Kschiwan, M. Schwefer, S. Neiner, S. Hettwer, M. Haeussler-Schuchardt, R. Degenhardt, S. Sennhenn, M. Brendel, A. Stoehr, W. Widjaja, S. Loehndorf, A. Logemann, J. Hoskamp, J. Grundt, M. Block, R. Ulrych, A. Reithmeier, V. Panagopoulos, C. Martignani, D. Bernucci, E. Fantecchi, I. Diemberger, M. Ziacchi, M. Biffi, P. Cimaglia, J. Frisoni, I. Giannini, S. Boni, S. Fumagalli, S. Pupo, A. Di Chiara, P. Mirone, F. Pesce, C. Zoccali, V.L. Malavasi, A. Mussagaliyeva, B. Ahyt, Z. Salihova, K. Koshum-Bayeva, A. Kerimkulova, A. Bairamukova, B. Lurina, R. Zuzans, S. Jegere, I. Mintale, K. Kupics, K. Jubele, O. Kalejs, K. Vanhear, M. Cachia, E. Abela, S. Warwicker, T. Tabone, R. Xuereb, D. Asanovic, D. Drakalovic, M. Vukmirovic, N. Pavlovic, L. Music, N. Bulatovic, A. Boskovic, H. Uiterwaal, N. Bijsterveld, J. De Groot, J. Neefs, N. van den Berg, F. Piersma, A. Wilde, V. Hagens, J. Van Es, J. Van Opstal, B. Van Rennes, H. Verheij, W. Breukers, G. Tjeerdsma, R. Nijmeijer, D. Wegink, R. Binnema, S. Said, S. Philippens, W. van Doorn, T. Szili-Torok, R. Bhagwandien, P. Janse, A. Muskens, M. van Eck, R. Gevers, N. van der Ven, A. Duygun, B. Rahel, J. Meeder, A. Vold, C. Holst Hansen, I. Engset, B. Dyduch-Fejklowicz, E. Koba, M. Cichocka, A. Sokal, A. Kubicius, E. Pruchniewicz, A. Kowalik-Sztylc, W. Czapla, I. Mróz, M. Kozlowski, T. Pawlowski, M. Tendera, A. Winiarska-Filipek, A. Fidyk, A. Slowikowski, M. Haberka, M. Lachor-Broda, M. Biedron, Z. Gasior, M. Kołodziej, M. Janion, I. Gorczyca-Michta, B. Wozakowska-Kaplon, M. Stasiak, P. Jakubowski, T. Ciurus, J. Drozdz, M. Simiera, P. Zajac, T. Wcislo, P. Zycinski, J. Kasprzak, A. Olejnik, E. Harc-Dyl, J. Miarka, M. Pasieka, M. Ziemińska-Łuć, W. Bujak, A. Śliwiński, A. Grech, J. Morka, K. Petrykowska, M. Prasał, G. Hordyński, P. Feusette, P. Lipski, A. Wester, W. Streb, J. Romanek, P. Woźniak, M. Chlebuś, P. Szafarz, W. Stanik, M. Zakrzewski, J. Kaźmierczak, A. Przybylska, E. Skorek, H. Błaszczyk, M. Stępień, S. Szabowski, W. Krysiak, M. Szymańska, J. Karasiński, J. Blicharz, M. Skura, K. Hałas, L. Michalczyk, Z. Orski, K. Krzyżanowski, A. Skrobowski, L. Zieliński, M. Tomaszewska-Kiecana, M. Dłużniewski, M. Kiliszek, M. Peller, M. Budnik, P. Balsam, G. Opolski, A. Tymińska, K. Ozierański, A. Wancerz, A. Borowiec, E. Majos, R. Dabrowski, H. Szwed, A. Musialik-Lydka, A. Leopold-Jadczyk, E. Jedrzejczyk-Patej, M. Koziel, M. Mazurek, K. Krzemien-Wolska, P. Starosta, E. Nowalany-Kozielska, A. Orzechowska, M. Szpot, M. Staszel, S. Almeida, H. Pereira, L. Brandão Alves, R. Miranda, L. Ribeiro, F. Costa, F. Morgado, P. Carmo, P. Galvao Santos, R. Bernardo, P. Adragão, G. Ferreira da Silva, M. Peres, M. Alves, M. Leal, A. Cordeiro, P. Magalhães, P. Fontes, S. Leão, A. Delgado, A. Costa, B. Marmelo, B. Rodrigues, D. Moreira, J. Santos, L. Santos, A. Terchet, D. Darabantiu, S. Mercea, V. Turcin Halka, A. Pop Moldovan, A. Gabor, B. Doka, G. Catanescu, H. Rus, L. Oboroceanu, E. Bobescu, R. Popescu, A. Dan, A. Buzea, I. Daha, G. Dan, I. Neuhoff, M. Baluta, R. Ploesteanu, N. Dumitrache, M. Vintila, A. Daraban, C. Japie, E. Badila, H. Tewelde, M. Hostiuc, S. Frunza, E. Tintea, D. Bartos, A. Ciobanu, I. Popescu, N. Toma, C. Gherghinescu, D. Cretu, N. Patrascu, C. Stoicescu, C. Udroiu, G. Bicescu, V. Vintila, D. Vinereanu, M. Cinteza, R. Rimbas, M. Grecu, A. Cozma, F. Boros, M. Ille, O. Tica, R. Tor, A. Corina, A. Jeewooth, B. Maria, C. Georgiana, C. Natalia, D. Alin, D. Dinu-Andrei, M. Livia, R. Daniela, R. Larisa, S. Umaar, T. Tamara, M. Ioachim Popescu, D. Nistor, I. Sus, O. Coborosanu, N. Alina-Ramona, R. Dan, L. Petrescu, G. Ionescu, C. Vacarescu, E. Goanta, M. Mangea, A. Ionac, C. Mornos, D. Cozma, S. Pescariu, E. Solodovnicova, I. Soldatova, J. Shutova, L. Tjuleneva, T. Zubova, V. Uskov, D. Obukhov, G. Rusanova, N. Isakova, S. Odinsova, T. Arhipova, E. Kazakevich, O. Zavyalova, T. Novikova, I. Riabaia, S. Zhigalov, E. Drozdova, I. Luchkina, Y. Monogarova, D. Hegya, L. Rodionova, V. Nevzorova, O. Lusanova, A. Arandjelovic, D. Toncev, L. Vukmirovic, M. Radisavljevic, M. Milanov, N. Sekularac, M. Zdravkovic, S. Hinic, S. Dimkovic, T. Acimovic, J. Saric, S. Radovanovic, A. Kocijancic, B. Obrenovic-Kircanski, D. Kalimanovska Ostric, D. Simic, I. Jovanovic, I. Petrovic, M. Polovina, M. Vukicevic, M. Tomasevic, N. Mujovic, N. Radivojevic, O. Petrovic, S. Aleksandric, V. Kovacevic, Z. Mijatovic, B. Ivanovic, M. Tesic, A. Ristic, B. Vujisic-Tesic, M. Nedeljkovic, A. Karadzic, A. Uscumlic, M. Prodanovic, M. Zlatar, M. Asanin, B. Bisenic, V. Vasic, Z. Popovic, D. Djikic, M. Sipic, V. Peric, B. Dejanovic, N. Milosevic, S. Backovic, A. Stevanovic, A. Andric, B. Pencic, M. Pavlovic-Kleut, V. Celic, M. Pavlovic, M. Petrovic, M. Vuleta, N. Petrovic, S. Simovic, Z. Savovic, S. Milanov, G. Davidovic, V. Iric-Cupic, D. Djordjevic, M. Damjanovic, S. Zdravkovic, V. Topic, D. Stanojevic, M. Randjelovic, R. Jankovic-Tomasevic, V. Atanaskovic, S. Antic, D. Simonovic, M. Stojanovic, S. Stojanovic, V. Mitic, V. Ilic, D. Petrovic, M. Deljanin Ilic, S. Ilic, V. Stoickov, S. Markovic, A. Mijatovic, D. Tanasic, G. Radakovic, J. Peranovic, N. Panic-Jelic, O. Vujadinovic, P. Pajic, S. Bekic, S. Kovacevic, A. García Fernandez, A. Perez Cabeza, M. Anguita, L. Tercedor Sanchez, E. Mau, J. Loayssa, M. Ayarra, M. Carpintero, I. Roldán Rabadan, M. Gil Ortega, A. Tello Montoliu, E. Orenes Piñero, S. Manzano Fernández, F. Marín, A. Romero Aniorte, A. Veliz Martínez, M. Quintana Giner, G. Ballesteros, M. Palacio, O. Alcalde, I. García-Bolao, V. Bertomeu Gonzalez, F. Otero-Raviña, J. García Seara, J. Gonzalez Juanatey, N. Dayal, P. Maziarski, P. Gentil-Baron, M. Koç, E. Onrat, I.E. Dural, K. Yilmaz, B. Özin, S. Tan Kurklu, Y. Atmaca, U. Canpolat, L. Tokgozoglu, A.K. Dolu, B. Demirtas, D. Sahin, O. Ozcan Celebi, G. Gagirci, U.O. Turk, H. Ari, N. Polat, N. Toprak, M. Sucu, O. Akin Serdar, A. Taha Alper, A. Kepez, Y. Yuksel, A. Uzunselvi, S. Yuksel, M. Sahin, O. Kayapinar, T. Ozcan, H. Kaya, M.B. Yilmaz, M. Kutlu, M. Demir, C. Gibbs, S. Kaminskiene, M. Bryce, A. Skinner, G. Belcher, J. Hunt, L. Stancombe, B. Holbrook, C. Peters, S. Tettersell, A. Shantsila, K. Senoo, M. Proietti, K. Russell, P. Domingos, S. Hussain, J. Partridge, R. Haynes, S. Bahadur, R. Brown, S. McMahon, J. McDonald, K. Balachandran, R. Singh, S. Garg, H. Desai, K. Davies, W. Goddard, G. Galasko, I. Rahman, Y. Chua, O. Payne, S. Preston, O. Brennan, L. Pedley, C. Whiteside, C. Dickinson, J. Brown, K. Jones, L. Benham, R. Brady, L. Buchanan, A. Ashton, H. Crowther, H. Fairlamb, S. Thornthwaite, C. Relph, A. McSkeane, U. Poultney, N. Kelsall, P. Rice, T. Wilson, M. Wrigley, R. Kaba, T. Patel, E. Young, J. Law, C. Runnett, H. Thomas, H. McKie, J. Fuller, S. Pick, A. Sharp, A. Hunt, K. Thorpe, C. Hardman, E. Cusack, L. Adams, M. Hough, S. Keenan, A. Bowring, J. Watts, J. Zaman, K. Goffin, H. Nutt, Y. Beerachee, J. Featherstone, C. Mills, J. Pearson, L. Stephenson, S. Grant, A. Wilson, C. Hawksworth, I. Alam, M. Robinson, S. Ryan, R. Egdell, E. Gibson, M. Holland, D. Leonard, B. Mishra, S. Ahmad, H. Randall, J. Hill, L. Reid, M. George, S. McKinley, L. Brockway, W. Milligan, J. Sobolewska, J. Muir, L. Tuckis, L. Winstanley, P. Jacob, S. Kaye, L. Morby, A. Jan, T. Sewell, C. Boos, B. Wadams, C. Cope, P. Jefferey, N. Andrews, A. Getty, A. Suttling, C. Turner, K. Hudson, R. Austin, S. Howe, R. Iqbal, N. Gandhi, K. Brophy, P. Mirza, E. Willard, S. Collins, N. Ndlovu, E. Subkovas, V. Karthikeyan, L. Waggett, A. Wood, A. Bolger, J. Stockport, L. Evans, E. Harman, J. Starling, L. Williams, V. Saul, M. Sinha, L. Bell, S. Tudgay, S. Kemp, L. Frost, T. Ingram, A. Loughlin, C. Adams, M. Adams, F. Hurford, C. Owen, C. Miller, D. Donaldson, H. Tivenan, H. Button, A. Nasser, O. Jhagra, B. Stidolph, C. Brown, C. Livingstone, M. Duffy, P. Madgwick, P. Roberts, E. Greenwood, L. Fletcher, M. Beveridge, S. Earles, D. McKenzie, D. Beacock, M. Dayer, M. Seddon, D. Greenwell, F. Luxton, F. Venn, H. Mills, J. Rewbury, K. James, K. Roberts, L. Tonks, D. Felmeden, W. Taggu, A. Summerhayes, D. Hughes, J. Sutton, L. Felmeden, M. Khan, E. Walker, L. Norris, L. O'Donohoe, A. Mozid, H. Dymond, H. Lloyd-Jones, G. Saunders, D. Simmons, D. Coles, D. Cotterill, S. Beech, S. Kidd, B. Wrigley, S. Petkar, A. Smallwood, R. Jones, E. Radford, S. Milgate, S. Metherell, V. Cottam, C. Buckley, A. Broadley, D. Wood, J. Allison, K. Rennie, L. Balian, L. Howard, L. Pippard, S. Board, T. Pitt-Kerby, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Océan du Large et Variabilité Climatique (OLVAC), Laboratoire d'études en Géophysique et océanographie spatiales (LEGOS), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire Midi-Pyrénées (OMP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Institut de Recherche pour le Développement (IRD)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Institut de Recherche pour le Développement (IRD)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Centre National de la Recherche Scientifique (CNRS), Uppsala University, University of Belgrade [Belgrade], CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Éducation Éthique Santé EA 7505 (EES), and Université de Tours (UT)
- Subjects
Kardiologi ,General Practice ,Cohort ,Anticoagulants ,MACE ,Endocrinology and Diabetes ,Prognosis ,[SHS]Humanities and Social Sciences ,Allmänmedicin ,Stroke ,Risk Factors ,Healthcare resource utilisation ,Mortality ,Prevalence ,Endokrinologi och diabetes ,Atrial Fibrillation ,Internal Medicine ,Diabetes Mellitus ,Quality of Life ,Humans ,Cardiac and Cardiovascular Systems ,Prospective Studies ,Registries ,Aged - Abstract
BACKGROUND: The prevalence of atrial fibrillation(AF) and diabetes mellitus is rising to epidemic proportions. We aimed to assess the impact of diabetes on the management and outcomes of patients with AF.METHODS: The EORP-AF General Long-Term Registry is a prospective, observational registry from 250 centres across 27 European countries. Outcomes of interest were as follows: i)rhythm control interventions; ii)quality of life; iii)healthcare resource utilisation; and iv)major adverse events.RESULTS: Of 11,028 patients with AF, the median age was 71 (63-77) years and 2537 (23.0%) had diabetes. Median follow-up was 24 months. Diabetes was related to increased use of anticoagulation but less rhythm control interventions. Using multivariable analysis, at 2-year follow-up, patients with diabetes were associated with greater levels of anxiety (p = 0.038) compared to those without diabetes. Overall, diabetes was associated with worse health during follow-up, as indicated by Health Utility Score and Visual Analogue Scale. Healthcare resource utilisation was greater with diabetes in terms of length of hospital stay (8.1 (±8.2) vs. 6.1 (±6.7) days); cardiology and internal medicine/general practitioner visits; and emergency room admissions. Diabetes was an independent risk factor of major adverse cardiovascular event (MACE; HR 1.26 [95% CI, 1.04-1.52]), all-cause mortality (HR 1.28 [95% CI, 1.08-1.52]), and cardiovascular mortality (HR 1.41 [95% CI, 1.09-1.83]).CONCLUSION: In this contemporary AF cohort, diabetes was present in 1 in 4 patients and it served as an independent risk factor for reduced quality of life, greater healthcare resource utilisation and excess MACE, all-cause mortality and cardiovascular mortality. There was increased use of anticoagulation therapy in diabetes but with less rhythm control interventions.
- Published
- 2022
- Full Text
- View/download PDF
4. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
- Author
-
Marco Vitolo, Vincenzo L. Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana S. Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo Pietro Maggioni, Deirdre A. Lane, Gregory Y.H. Lip, Giuseppe Boriani, G. Boriani, G.Y.H. Lip, L. Tavazzi, A.P. Maggioni, G-A. Dan, T. Potpara, M. Nabauer, F. Marin, Z. Kalarus, L. Fauchier, A. Goda, G. Mairesse, T. Shalganov, L. Antoniades, M. Taborsky, S. Riahi, P. Muda, I. García Bolao, O. Piot, K. Etsadashvili, M. Haim, A. Azhari, J. Najafian, M. Santini, E. Mirrakhimov, K. Kulzida, A. Erglis, L. Poposka, M.R. Burg, H. Crijns, Ö. Erküner, D. Atar, R. Lenarczyk, M. Martins Oliveira, D. Shah, E. Serdechnaya, E. Diker, E. Zëra, U. Ekmekçiu, V. Paparisto, M. Tase, H. Gjergo, J. Dragoti, M. Ciutea, N. Ahadi, Z. el Husseini, M. Raepers, J. Leroy, P. Haushan, A. Jourdan, C. Lepiece, L. Desteghe, J. Vijgen, P. Koopman, G. Van Genechten, H. Heidbuchel, T. Boussy, M. De Coninck, H. Van Eeckhoutte, N. Bouckaert, A. Friart, J. Boreux, C. Arend, P. Evrard, L. Stefan, E. Hoffer, J. Herzet, M. Massoz, C. Celentano, M. Sprynger, L. Pierard, P. Melon, B. Van Hauwaert, C. Kuppens, D. Faes, D. Van Lier, A. Van Dorpe, A. Gerardy, O. Deceuninck, O. Xhaet, F. Dormal, E. Ballant, D. Blommaert, D. Yakova, M. Hristov, T. Yncheva, N. Stancheva, S. Tisheva, M. Tokmakova, F. Nikolov, D. Gencheva, B. Kunev, M. Stoyanov, D. Marchov, V. Gelev, V. Traykov, A. Kisheva, H. Tsvyatkov, R. Shtereva, S. Bakalska-Georgieva, S. Slavcheva, Y. Yotov, M. Kubíčková, A. Marni Joensen, A. Gammelmark, L. Hvilsted Rasmussen, P. Dinesen, S. Krogh Venø, B. Sorensen, A. Korsgaard, K. Andersen, C. Fragtrup Hellum, A. Svenningsen, O. Nyvad, P. Wiggers, O. May, A. Aarup, B. Graversen, L. Jensen, M. Andersen, M. Svejgaard, S. Vester, S. Hansen, V. Lynggaard, M. Ciudad, R. Vettus, A. Maestre, S. Castaño, S. Cheggour, J. Poulard, V. Mouquet, S. Leparrée, J. Bouet, J. Taieb, A. Doucy, H. Duquenne, A. Furber, J. Dupuis, J. Rautureau, M. Font, P. Damiano, M. Lacrimini, J. Abalea, S. Boismal, T. Menez, J. Mansourati, G. Range, H. Gorka, C. Laure, C. Vassalière, N. Elbaz, N. Lellouche, K. Djouadi, F. Roubille, D. Dietz, J. Davy, M. Granier, P. Winum, C. Leperchois-Jacquey, H. Kassim, E. Marijon, J. Le Heuzey, J. Fedida, C. Maupain, C. Himbert, E. Gandjbakhch, F. Hidden-Lucet, G. Duthoit, N. Badenco, T. Chastre, X. Waintraub, M. Oudihat, J. Lacoste, C. Stephan, H. Bader, N. Delarche, L. Giry, D. Arnaud, C. Lopez, F. Boury, I. Brunello, M. Lefèvre, R. Mingam, M. Haissaguerre, M. Le Bidan, D. Pavin, V. Le Moal, C. Leclercq, T. Beitar, I. Martel, A. Schmid, N. Sadki, C. Romeyer-Bouchard, A. Da Costa, I. Arnault, M. Boyer, C. Piat, N. Lozance, S. Nastevska, A. Doneva, B. Fortomaroska Milevska, B. Sheshoski, K. Petroska, N. Taneska, N. Bakrecheski, K. Lazarovska, S. Jovevska, V. Ristovski, A. Antovski, E. Lazarova, I. Kotlar, J. Taleski, S. Kedev, N. Zlatanovik, S. Jordanova, T. Bajraktarova Proseva, S. Doncovska, D. Maisuradze, A. Esakia, E. Sagirashvili, K. Lartsuliani, N. Natelashvili, N. Gumberidze, R. Gvenetadze, N. Gotonelia, N. Kuridze, G. Papiashvili, I. Menabde, S. Glöggler, A. Napp, C. Lebherz, H. Romero, K. Schmitz, M. Berger, M. Zink, S. Köster, J. Sachse, E. Vonderhagen, G. Soiron, K. Mischke, R. Reith, M. Schneider, W. Rieker, D. Boscher, A. Taschareck, A. Beer, D. Oster, O. Ritter, J. Adamczewski, S. Walter, A. Frommhold, E. Luckner, J. Richter, M. Schellner, S. Landgraf, S. Bartholome, R. Naumann, J. Schoeler, D. Westermeier, F. William, K. Wilhelm, M. Maerkl, R. Oekinghaus, M. Denart, M. Kriete, U. Tebbe, T. Scheibner, M. Gruber, A. Gerlach, C. Beckendorf, L. Anneken, M. Arnold, S. Lengerer, Z. Bal, C. Uecker, H. Förtsch, S. Fechner, V. Mages, E. Martens, H. Methe, T. Schmidt, B. Schaeffer, B. Hoffmann, J. Moser, K. Heitmann, S. Willems, C. Klaus, I. Lange, M. Durak, E. Esen, F. Mibach, H. Mibach, A. Utech, M. Gabelmann, R. Stumm, V. Ländle, C. Gartner, C. Goerg, N. Kaul, S. Messer, D. Burkhardt, C. Sander, R. Orthen, S. Kaes, A. Baumer, F. Dodos, A. Barth, G. Schaeffer, J. Gaertner, J. Winkler, A. Fahrig, J. Aring, I. Wenzel, S. Steiner, A. Kliesch, E. Kratz, K. Winter, P. Schneider, A. Haag, I. Mutscher, R. Bosch, J. Taggeselle, S. Meixner, A. Schnabel, A. Shamalla, H. Hötz, A. Korinth, C. Rheinert, G. Mehltretter, B. Schön, N. Schön, A. Starflinger, E. Englmann, G. Baytok, T. Laschinger, G. Ritscher, A. Gerth, D. Dechering, L. Eckardt, M. Kuhlmann, N. Proskynitopoulos, J. Brunn, K. Foth, C. Axthelm, H. Hohensee, K. Eberhard, S. Turbanisch, N. Hassler, A. Koestler, G. Stenzel, D. Kschiwan, M. Schwefer, S. Neiner, S. Hettwer, M. Haeussler-Schuchardt, R. Degenhardt, S. Sennhenn, M. Brendel, A. Stoehr, W. Widjaja, S. Loehndorf, A. Logemann, J. Hoskamp, J. Grundt, M. Block, R. Ulrych, A. Reithmeier, V. Panagopoulos, C. Martignani, D. Bernucci, E. Fantecchi, I. Diemberger, M. Ziacchi, M. Biffi, P. Cimaglia, J. Frisoni, I. Giannini, S. Boni, S. Fumagalli, S. Pupo, A. Di Chiara, P. Mirone, F. Pesce, C. Zoccali, V.L. Malavasi, A. Mussagaliyeva, B. Ahyt, Z. Salihova, K. Koshum-Bayeva, A. Kerimkulova, A. Bairamukova, B. Lurina, R. Zuzans, S. Jegere, I. Mintale, K. Kupics, K. Jubele, O. Kalejs, K. Vanhear, M. Burg, M. Cachia, E. Abela, S. Warwicker, T. Tabone, R. Xuereb, D. Asanovic, D. Drakalovic, M. Vukmirovic, N. Pavlovic, L. Music, N. Bulatovic, A. Boskovic, H. Uiterwaal, N. Bijsterveld, J. De Groot, J. Neefs, N. van den Berg, F. Piersma, A. Wilde, V. Hagens, J. Van Es, J. Van Opstal, B. Van Rennes, H. Verheij, W. Breukers, G. Tjeerdsma, R. Nijmeijer, D. Wegink, R. Binnema, S. Said, S. Philippens, W. van Doorn, T. Szili-Torok, R. Bhagwandien, P. Janse, A. Muskens, M. van Eck, R. Gevers, N. van der Ven, A. Duygun, B. Rahel, J. Meeder, A. Vold, C. Holst Hansen, I. Engset, B. Dyduch-Fejklowicz, E. Koba, M. Cichocka, A. Sokal, A. Kubicius, E. Pruchniewicz, A. Kowalik-Sztylc, W. Czapla, I. Mróz, M. Kozlowski, T. Pawlowski, M. Tendera, A. Winiarska-Filipek, A. Fidyk, A. Slowikowski, M. Haberka, M. Lachor-Broda, M. Biedron, Z. Gasior, M. Kołodziej, M. Janion, I. Gorczyca-Michta, B. Wozakowska-Kaplon, M. Stasiak, P. Jakubowski, T. Ciurus, J. Drozdz, M. Simiera, P. Zajac, T. Wcislo, P. Zycinski, J. Kasprzak, A. Olejnik, E. Harc-Dyl, J. Miarka, M. Pasieka, M. Ziemińska-Łuć, W. Bujak, A. Śliwiński, A. Grech, J. Morka, K. Petrykowska, M. Prasał, G. Hordyński, P. Feusette, P. Lipski, A. Wester, W. Streb, J. Romanek, P. Woźniak, M. Chlebuś, P. Szafarz, W. Stanik, M. Zakrzewski, J. Kaźmierczak, A. Przybylska, E. Skorek, H. Błaszczyk, M. Stępień, S. Szabowski, W. Krysiak, M. Szymańska, J. Karasiński, J. Blicharz, M. Skura, K. Hałas, L. Michalczyk, Z. Orski, K. Krzyżanowski, A. Skrobowski, L. Zieliński, M. Tomaszewska-Kiecana, M. Dłużniewski, M. Kiliszek, M. Peller, M. Budnik, P. Balsam, G. Opolski, A. Tymińska, K. Ozierański, A. Wancerz, A. Borowiec, E. Majos, R. Dabrowski, H. Szwed, A. Musialik-Lydka, A. Leopold-Jadczyk, E. Jedrzejczyk-Patej, M. Koziel, M. Mazurek, K. Krzemien-Wolska, P. Starosta, E. Nowalany-Kozielska, A. Orzechowska, M. Szpot, M. Staszel, S. Almeida, H. Pereira, L. Brandão Alves, R. Miranda, L. Ribeiro, F. Costa, F. Morgado, P. Carmo, P. Galvao Santos, R. Bernardo, P. Adragão, G. Ferreira da Silva, M. Peres, M. Alves, M. Leal, A. Cordeiro, P. Magalhães, P. Fontes, S. Leão, A. Delgado, A. Costa, B. Marmelo, B. Rodrigues, D. Moreira, J. Santos, L. Santos, A. Terchet, D. Darabantiu, S. Mercea, V. Turcin Halka, A. Pop Moldovan, A. Gabor, B. Doka, G. Catanescu, H. Rus, L. Oboroceanu, E. Bobescu, R. Popescu, A. Dan, A. Buzea, I. Daha, G. Dan, I. Neuhoff, M. Baluta, R. Ploesteanu, N. Dumitrache, M. Vintila, A. Daraban, C. Japie, E. Badila, H. Tewelde, M. Hostiuc, S. Frunza, E. Tintea, D. Bartos, A. Ciobanu, I. Popescu, N. Toma, C. Gherghinescu, D. Cretu, N. Patrascu, C. Stoicescu, C. Udroiu, G. Bicescu, V. Vintila, D. Vinereanu, M. Cinteza, R. Rimbas, M. Grecu, A. Cozma, F. Boros, M. Ille, O. Tica, R. Tor, A. Corina, A. Jeewooth, B. Maria, C. Georgiana, C. Natalia, D. Alin, D. Dinu-Andrei, M. Livia, R. Daniela, R. Larisa, S. Umaar, T. Tamara, M. Ioachim Popescu, D. Nistor, I. Sus, O. Coborosanu, N. Alina-Ramona, R. Dan, L. Petrescu, G. Ionescu, C. Vacarescu, E. Goanta, M. Mangea, A. Ionac, C. Mornos, D. Cozma, S. Pescariu, E. Solodovnicova, I. Soldatova, J. Shutova, L. Tjuleneva, T. Zubova, V. Uskov, D. Obukhov, G. Rusanova, N. Isakova, S. Odinsova, T. Arhipova, E. Kazakevich, O. Zavyalova, T. Novikova, I. Riabaia, S. Zhigalov, E. Drozdova, I. Luchkina, Y. Monogarova, D. Hegya, L. Rodionova, V. Nevzorova, O. Lusanova, A. Arandjelovic, D. Toncev, L. Vukmirovic, M. Radisavljevic, M. Milanov, N. Sekularac, M. Zdravkovic, S. Hinic, S. Dimkovic, T. Acimovic, J. Saric, S. Radovanovic, A. Kocijancic, B. Obrenovic-Kircanski, D. Kalimanovska Ostric, D. Simic, I. Jovanovic, I. Petrovic, M. Polovina, M. Vukicevic, M. Tomasevic, N. Mujovic, N. Radivojevic, O. Petrovic, S. Aleksandric, V. Kovacevic, Z. Mijatovic, B. Ivanovic, M. Tesic, A. Ristic, B. Vujisic-Tesic, M. Nedeljkovic, A. Karadzic, A. Uscumlic, M. Prodanovic, M. Zlatar, M. Asanin, B. Bisenic, V. Vasic, Z. Popovic, D. Djikic, M. Sipic, V. Peric, B. Dejanovic, N. Milosevic, S. Backovic, A. Stevanovic, A. Andric, B. Pencic, M. Pavlovic-Kleut, V. Celic, M. Pavlovic, M. Petrovic, M. Vuleta, N. Petrovic, S. Simovic, Z. Savovic, S. Milanov, G. Davidovic, V. Iric-Cupic, D. Djordjevic, M. Damjanovic, S. Zdravkovic, V. Topic, D. Stanojevic, M. Randjelovic, R. Jankovic-Tomasevic, V. Atanaskovic, S. Antic, D. Simonovic, M. Stojanovic, S. Stojanovic, V. Mitic, V. Ilic, D. Petrovic, M. Deljanin Ilic, S. Ilic, V. Stoickov, S. Markovic, A. Mijatovic, D. Tanasic, G. Radakovic, J. Peranovic, N. Panic-Jelic, O. Vujadinovic, P. Pajic, S. Bekic, S. Kovacevic, A. García Fernandez, A. Perez Cabeza, M. Anguita, L. Tercedor Sanchez, E. Mau, J. Loayssa, M. Ayarra, M. Carpintero, I. Roldán Rabadan, M. Gil Ortega, A. Tello Montoliu, E. Orenes Piñero, S. Manzano Fernández, F. Marín, A. Romero Aniorte, A. Veliz Martínez, M. Quintana Giner, G. Ballesteros, M. Palacio, O. Alcalde, I. García-Bolao, V. Bertomeu Gonzalez, F. Otero-Raviña, J. García Seara, J. Gonzalez Juanatey, N. Dayal, P. Maziarski, P. Gentil-Baron, M. Koç, E. Onrat, I.E. Dural, K. Yilmaz, B. Özin, S. Tan Kurklu, Y. Atmaca, U. Canpolat, L. Tokgozoglu, A.K. Dolu, B. Demirtas, D. Sahin, O. Ozcan Celebi, G. Gagirci, U.O. Turk, H. Ari, N. Polat, N. Toprak, M. Sucu, O. Akin Serdar, A. Taha Alper, A. Kepez, Y. Yuksel, A. Uzunselvi, S. Yuksel, M. Sahin, O. Kayapinar, T. Ozcan, H. Kaya, M.B. Yilmaz, M. Kutlu, M. Demir, C. Gibbs, S. Kaminskiene, M. Bryce, A. Skinner, G. Belcher, J. Hunt, L. Stancombe, B. Holbrook, C. Peters, S. Tettersell, A. Shantsila, D. Lane, K. Senoo, M. Proietti, K. Russell, P. Domingos, S. Hussain, J. Partridge, R. Haynes, S. Bahadur, R. Brown, S. McMahon, J. McDonald, K. Balachandran, R. Singh, S. Garg, H. Desai, K. Davies, W. Goddard, G. Galasko, I. Rahman, Y. Chua, O. Payne, S. Preston, O. Brennan, L. Pedley, C. Whiteside, C. Dickinson, J. Brown, K. Jones, L. Benham, R. Brady, L. Buchanan, A. Ashton, H. Crowther, H. Fairlamb, S. Thornthwaite, C. Relph, A. McSkeane, U. Poultney, N. Kelsall, P. Rice, T. Wilson, M. Wrigley, R. Kaba, T. Patel, E. Young, J. Law, C. Runnett, H. Thomas, H. McKie, J. Fuller, S. Pick, A. Sharp, A. Hunt, K. Thorpe, C. Hardman, E. Cusack, L. Adams, M. Hough, S. Keenan, A. Bowring, J. Watts, J. Zaman, K. Goffin, H. Nutt, Y. Beerachee, J. Featherstone, C. Mills, J. Pearson, L. Stephenson, S. Grant, A. Wilson, C. Hawksworth, I. Alam, M. Robinson, S. Ryan, R. Egdell, E. Gibson, M. Holland, D. Leonard, B. Mishra, S. Ahmad, H. Randall, J. Hill, L. Reid, M. George, S. McKinley, L. Brockway, W. Milligan, J. Sobolewska, J. Muir, L. Tuckis, L. Winstanley, P. Jacob, S. Kaye, L. Morby, A. Jan, T. Sewell, C. Boos, B. Wadams, C. Cope, P. Jefferey, N. Andrews, A. Getty, A. Suttling, C. Turner, K. Hudson, R. Austin, S. Howe, R. Iqbal, N. Gandhi, K. Brophy, P. Mirza, E. Willard, S. Collins, N. Ndlovu, E. Subkovas, V. Karthikeyan, L. Waggett, A. Wood, A. Bolger, J. Stockport, L. Evans, E. Harman, J. Starling, L. Williams, V. Saul, M. Sinha, L. Bell, S. Tudgay, S. Kemp, L. Frost, T. Ingram, A. Loughlin, C. Adams, M. Adams, F. Hurford, C. Owen, C. Miller, D. Donaldson, H. Tivenan, H. Button, A. Nasser, O. Jhagra, B. Stidolph, C. Brown, C. Livingstone, M. Duffy, P. Madgwick, P. Roberts, E. Greenwood, L. Fletcher, M. Beveridge, S. Earles, D. McKenzie, D. Beacock, M. Dayer, M. Seddon, D. Greenwell, F. Luxton, F. Venn, H. Mills, J. Rewbury, K. James, K. Roberts, L. Tonks, D. Felmeden, W. Taggu, A. Summerhayes, D. Hughes, J. Sutton, L. Felmeden, M. Khan, E. Walker, L. Norris, L. O'Donohoe, A. Mozid, H. Dymond, H. Lloyd-Jones, G. Saunders, D. Simmons, D. Coles, D. Cotterill, S. Beech, S. Kidd, B. Wrigley, S. Petkar, A. Smallwood, R. Jones, E. Radford, S. Milgate, S. Metherell, V. Cottam, C. Buckley, A. Broadley, D. Wood, J. Allison, K. Rennie, L. Balian, L. Howard, L. Pippard, S. Board, and T. Pitt-Kerby
- Subjects
Male ,AF registry ,Atrial fibrillation ,Biomarkers ,Death ,Major adverse cardiovascular events ,outcomes ,Troponins ,Troponin ,Risk Factors ,Atrial Fibrillation ,Internal Medicine ,Humans ,Female ,Prospective Studies ,Registries ,Aged - Abstract
BACKGROUND: Cardiac troponins (cTn) have been reported to be predictors for adverse outcomes in atrial fibrillation (AF), patients, but their actual use is still unclear.AIM: To assess the factors associated with cTn testing in routine practice and evaluate the association with outcomes.METHODS: Patients enrolled in the ESC-EHRA EORP-AF General Long-Term Registry were stratified into 3 groups according to cTn levels as (i) cTn not tested, (ii) cTn in range (≤99th percentile), (iii) cTn elevated (>99th percentile). The composite outcome of any thromboembolism /any acute coronary syndrome/cardiovascular (CV) death, defined as Major Adverse Cardiovascular Events (MACE) and all-cause death were the main endpoints.RESULTS: Among 10 445 AF patients (median age 71 years, 40.3% females) cTn were tested in 2834 (27.1%). cTn was elevated in 904/2834 (31.9%) and in-range in 1930/2834 (68.1%) patients. Female sex, in-hospital enrollment, first-detected AF, CV risk factors, history of coronary artery disease, and atypical AF symptoms were independently associated with cTn testing. Elevated cTn were independently associated with a higher risk for MACE (Model 1, hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.40-2.16, Model 2, HR 1.62, 95% CI 1.28-2.05; Model 3 HR 1.76, 95% CI 1.37-2.26) and all-cause death (Model 1, HR 1.45, 95% CI 1.21-1.74; Model 2, HR 1.36, 95% CI 1.12-1.66; Model 3, HR 1.38, 95% CI 1.12-1.71).CONCLUSIONS: Elevated cTn levels were associated with an increased risk of all-cause mortality and adverse CV events. Clinical factors that might enhance the need to rule out CAD were associated with cTn testing.
- Published
- 2022
- Full Text
- View/download PDF
5. Aged Eisenia fetida earthworms exhibit decreased reproductive success
- Author
-
K. A. Penning and D. M. Wrigley
- Subjects
0106 biological sciences ,0301 basic medicine ,Eisenia fetida ,Reproductive success ,media_common.quotation_subject ,Earthworm ,Zoology ,Biology ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,03 medical and health sciences ,Adult life ,030104 developmental biology ,Oligochaeta ,Animal Science and Zoology ,Reproduction ,Hatchling ,Sperm counts ,Developmental Biology ,media_common - Abstract
The effect of age on male and female reproductive activities was examined in 1–6-year-old age-matched populations of the simultaneous hermaphroditic earthworm, Eisenia fetida, (Annelida; Oligochaeta). As earthworm ages increase from 3 to 6 years, cocoon and hatchling production gradually decreased. Sperm counts from 2-year-old and 5-year-old earthworms did not differ. Old earthworms successfully inseminated young virgin earthworms. Thus, female functions associated with successful cocoon production diminish before the male function. These results indicate that E. fetida earthworms spend up to one-third of their adult life with limited reproductive capabilities.
- Published
- 2017
- Full Text
- View/download PDF
6. The economic recession and subjective well-being in older adults in the Republic of Ireland
- Author
-
Brendan D. Kelly, M Wrigley, K Mullin, S O'Dwyer, and Richard M. Duffy
- Subjects
Employment ,Male ,media_common.quotation_subject ,Recession ,The Republic ,03 medical and health sciences ,Diagnostic Self Evaluation ,0302 clinical medicine ,Economic situation ,History and Philosophy of Science ,Surveys and Questionnaires ,Humans ,030212 general & internal medicine ,Subjective well-being ,Applied Psychology ,Social policy ,media_common ,Aged ,Mental health ,Confidence interval ,030227 psychiatry ,European Social Survey ,Psychiatry and Mental health ,Cross-Sectional Studies ,Economic Recession ,Mental Health ,Female ,Psychology ,Ireland ,Demography - Abstract
ObjectiveSubjective well-being in older people is strongly associated with emotional, physical and mental health. This study investigates subjective well-being in older adults in Ireland before and after the economic recession that commenced in 2008.MethodsCross-sectional data from the biennial European Social Survey (2002–2012) were analysed for two separate groups of older adults: one sampled before the recession and one after. Stratification and linear regression modelling were used to analyse the association between subjective well-being, the recession and multiple potential confounders and effect modifiers.ResultsData were analysed on 2013 individuals. Overall, subjective well-being among older adults was 1.30 points lower after the recession compared with before the recession (s.e. 0.16; 95% confidence interval 1.00–1.61; ps.d. 3.24); post-recession:14.8 (s.d. 3.72)]. Among these older adults, the pre- and post-recession difference was especially marked in women, those with poor health and those living in urban areas.ConclusionsSubjective well-being was significantly lower in older adults after the recession compared with before the recession, especially in women with poor health in urban areas. Policy-makers need proactively to protect these vulnerable cohorts in future health and social policy. Future research could usefully focus on older people on fixed incomes whose diminished ability to alter their economic situation might make them more vulnerable to reduced subjective well-being during a recession.
- Published
- 2019
7. Multi-point Regression Voting for Shape Model Matching
- Author
-
Claudia Lindner, Paul A. Bromiley, M. Wrigley, Timothy F. Cootes, and Jessie Thomson
- Subjects
Random Forests ,0301 basic medicine ,Computer science ,media_common.quotation_subject ,Constrained Local Models ,02 engineering and technology ,computer.software_genre ,03 medical and health sciences ,Landmark Annotation ,Voting ,0202 electrical engineering, electronic engineering, information engineering ,Multi point ,General Environmental Science ,media_common ,Continuum (topology) ,Frame (networking) ,Regression ,Random forest ,030104 developmental biology ,DXA Imaging ,General Earth and Planetary Sciences ,020201 artificial intelligence & image processing ,Data mining ,Model matching ,Algorithm ,computer - Abstract
Regression-based schemes have proven effective for locating landmarks on images. Most previous approaches either predict the positions of all points simultaneously, or use regressors that predict individual points combined with a global shape constraint. The former can be efficient, but such models tend to be less robust. Conversely, Random Forest (RF) voting methods for individual points have been shown to be robust and accurate, but can lead to very large models. We explore the continuum between these two approaches by training RF regressors to predict subsets of points. Multi-point regression voting was implemented within the Random Forest Regression Voting Constrained Local Model frame- work and evaluated on clinical and facial images. Significant model size reductions were achieved with little difference in accuracy. The approach may therefore be useful where high numbers of points, and limitations on memory or disk space, make single-point models impractically large.
- Published
- 2016
- Full Text
- View/download PDF
8. 'A Curious Thing in the Medical Line'
- Author
-
Dorothy M. Wrigley
- Subjects
New england ,History ,Cowpox ,Law ,medicine ,Smallpox ,Variolation ,medicine.disease ,Microbiology ,Newspaper ,Infectious agent - Abstract
In 1799, a Boston newspaper, the Columbian Centinel, published a letter from a local physician, Benjamin Waterhouse (1754–1846), commenting on a British smallpox pamphlet. That letter, “A Curious Thing in the Medical Line,” introduced Centinel readers to the newly developed cowpox-based vaccine and also helped to launch a major program to control smallpox in the United States. During the next decade, Waterhouse zealously chronicled the pathogenesis of the cowpox infectious agent and its ability to induce immunity in humans to smallpox in the Centinel and dozens of similar newspapers throughout New England.
- Published
- 2012
- Full Text
- View/download PDF
9. Blast Crisis of Chronic Myeloid Leukaemia: The Effect of Intensive Chemotherapy
- Author
-
C. Gauci, E. Sikora, Peter F. M. Wrigley, M. E. J. Beard, G. Hamilton Fairley, and Barbara Kirk
- Subjects
Adult ,Male ,Vincristine ,medicine.medical_specialty ,Blast Crisis ,Adolescent ,Allopurinol ,Prednisolone ,Antineoplastic Agents ,Intensive chemotherapy ,Chronic myeloid leukaemia ,Drug Administration Schedule ,hemic and lymphatic diseases ,Internal medicine ,Chromosomes, Human, 21-22 and Y ,medicine ,Asparaginase ,Humans ,Initial treatment ,Thioguanine ,Intensive care medicine ,Aged ,Chromosome Aberrations ,Philadelphia Chromosome Positive ,business.industry ,Cytarabine ,Hematology ,Middle Aged ,Leukemia, Myeloid ,Drug Therapy, Combination ,Female ,business ,Median survival ,medicine.drug - Abstract
24 patients with Philadelphia chromosome positive chronic myeloid leukaemia (CML) in blast crisis were treated with intensive chemotherapy. 16 patients showed either partial or complete response to this treatment, but median survival remained short (13 weeks), and much of this time was spent in hospital. These results were not significantly better than those obtained by others using vincristine and prednisolone alone, and this combination of drugs can often be given on an outpatient basis. It is concluded that until more effective intensive therapy becomes available patients in CML blast crisis should be managed in such a way that the quality of life is not impaired; and that at present vincristine and prednisolone appears to be the most impaired; and that at present vincristine and prednisolone appears to be the most appropriate initial treatment, though even this is far from satisfactory.
- Published
- 2009
- Full Text
- View/download PDF
10. Architecture and Flow Patterns in Capillary Networks of Skeletal Muscle in Frog and Rat1
- Author
-
Christopher G. Ellis, A. C. Groom, R. F. Potter, and S M Wrigley
- Subjects
medicine.anatomical_structure ,Capillary action ,Chemistry ,medicine ,Skeletal muscle ,Anatomy ,Flow pattern - Published
- 2015
- Full Text
- View/download PDF
11. Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in hodgkin's disease
- Author
-
J. A. L. Amess, M. A. Horton, T. A. Lister, E. Dorey, Peter F. M. Wrigley, A. M. Oza, A. Z. S. Rohatiner, M. Leahy, and C. L. Davis
- Subjects
Adult ,Male ,Cancer Research ,Vincristine ,medicine.medical_specialty ,Leukocytosis ,medicine.medical_treatment ,Procarbazine ,Gastroenterology ,Drug Administration Schedule ,Immunophenotyping ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Infusions, Intravenous ,Etoposide ,Chemotherapy ,Chlorambucil ,business.industry ,Remission Induction ,Granulocyte-Macrophage Colony-Stimulating Factor ,Hematology ,General Medicine ,Middle Aged ,medicine.disease ,Hodgkin Disease ,Recombinant Proteins ,Vinblastine ,Endocrinology ,Oncology ,Prednisolone ,Female ,business ,Progressive disease ,medicine.drug - Abstract
Fourteen patients with Hodgkin's disease (two previously untreated, 12 following relapse or with refractory disease) were treated with a combination chemotherapy regimen comprising chlorambucil, vinblastine, procarbazine, prednisolone, etoposide, vincristine and adriamycin administered on days 1-8. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) (mammalian glycosylated, Sandoz/Schering-Plough) was administered after alternate cycles of chemotherapy from day 10 for 7 days by continuous intravenous (i.v.) infusion in 12 patients in a dose finding study (dose: 2 micrograms/kg/day in four patients, 4 micrograms/kg/day in four patients and 8 micrograms/kg/day in four patients) and by daily subcutaneous (s/c) injections in two patients (8 micrograms/kg/day). There was a rapid peripheral leucocytosis following the rhGM-CSF, reaching a peak at 1-2 days in 12/14 patients. The initial leucocytosis was composed of neutrophils followed by a rise in immature myeloid cells. There was no difference observed in the duration or depth of the nadir following chemotherapy or in the rate of recovery of peripheral white cell counts between cycles with and without rhGM-CSF in patients treated with 2 and 4 micrograms/kg/day. At the dose of 8 micrograms/kg/day, 3/6 patients had a shorter nadir duration in the cycle with rhGM-CSF, compared with cycle without rhGM-CSF. There was no difference in frequency of infection in cycles with and without rhGM-CSF. Following chemotherapy, six patients achieved clinical remission, six partial remission and two had progressive disease.
- Published
- 2006
- Full Text
- View/download PDF
12. Inhibition of Clostridium perfringens sporulation by Bacteroides fragilis and short-chain fatty acids
- Author
-
Dorothy M. Wrigley
- Subjects
chemistry.chemical_classification ,Isovalerate ,Fatty acid ,Biology ,Clostridium perfringens ,biology.organism_classification ,medicine.disease_cause ,Microbiology ,Spore ,chemistry.chemical_compound ,Infectious Diseases ,chemistry ,medicine ,Propionate ,Fermentation ,Bacteroides fragilis ,Antibiotic-associated diarrhea - Abstract
The effect a common fecal organism, Bacteroides fragilis, has on the sporulation of Clostridium perfringens, an organism linked to some cases of antibiotic associated diarrhea, was examined. Established B. fragilis cultures significantly decreased the number of heat resistant spores formed by C. perfringens ATCC 12915 and increased the number of vegetative cells. To determine if short-chain fatty acids (SCFA), fermentation products of B. fragilis, inhibited sporulation, the SCFA were added to sporulation broth. Sporulation decreased in the presence of acetate, isobutyrate, isovalerate, and succinate. Vegetative cell number for C. perfringens decreased in the cultures with isobutyrate. Propionate did not affect sporulation or vegetative cell number. The data support the hypothesis that the decrease in short-chain fatty acid concentration following antibiotic therapy predisposes patients to diarrheas caused by C. perfringens.
- Published
- 2004
- Full Text
- View/download PDF
13. So your quality system's certified but is it working for you?
- Author
-
M. Wrigley
- Subjects
Engineering ,Engineering management ,Quality management system ,business.industry ,General Engineering ,Systems engineering ,Auto evaluation ,Plan (drawing) ,Certification ,Management Science and Operations Research ,business ,PDCA ,Test (assessment) - Abstract
The author discusses the effectiveness of quality management systems (QMS), and describes an elementary test to determine if it's really working. An elementary test for checking the effectiveness of quality management systems is based on auto-evaluation, a 14 criteria test that falls into the 'plan', 'check' and 'act' phases of the Deming cycle. The author discusses the phases of this cycle.
- Published
- 2003
- Full Text
- View/download PDF
14. Irish gerontological society
- Author
-
P. Finucane, L. Giles, C. O’Sullivan, J. Duggan, A. Sexton, N. Atkins, E. O’Brien, A. Freyne, M. Wrigley, C. P. Maguire, M. Rowan, D. O’Neill, B. A. Lawlor, J. B. Walsh, D. Coakley, M. Cagney, J. Harbison, M. Crowe, D. Keating, R. F. Coen, C. A. O’Boyle, R. M. Doyle, N. P. Kennedy, S. Doyle, P. Gerrard-Dunne, D. G. Weir, R. Coen, K. Mulpeter, B. McNally, E. Daly, D. Harmon, E. Stokes, N. Kennedy, D. Gilchriest, A. E. Heaney, I. S. Young, T. R. O. Beringer, M. Kirby, G. R. J. Swanwick, I. Bruce, F. Buggy, P. Beausang, M. O’Connor, M. Hyland, C. Twomey, M. MacMahon, T. Smith, Wm. C. Love, C. J. Foy, A. P. Passmore, M. D. Vahidassr, M. Smye, I. Young, C. Cunningham, N. F. Horgan, N. Keane, P. Connolly, A. Mannion, A. Kelly, M. Power, J. Greene, C. W. Fan, B. McDonnell, Z. Johnson, M. Doona, R. Lawlor, C. Magee, P. McCormack, D. Nolan, P. Ó Mathúna, D. Lyons, T. J. Allain, S. Roy, M. Polkey, C. G. Swift, M. Heraty, E. M. Keane, S. O’Broin, B. Kelleher, M. P. O’Connor, C. Gaynor, D. Lynch, C. M. Hyland, D. Hanlon, P. Harrington, M. Ryan, R. Doyle, D. St. John Coss, S. Junejo, C. A. Donnellan, M. A. Gosney, D. Clinch, D. Hilton, B. O’Malley, S. Albloushi, J. N. Lavan, M. G. Courtney, E. Hardiman, M. Bolger, S. Pooransingh, W. Flannery, C. O’Malley, E. M. Horkan, F. Lundstrom, R. Webster, M. Threadgold, R. Hamill, F. Tracey, J. G. McConnell, I. C. Taylor, E. Duggan, A. Murphy, S. J. Nelson, I. M. Rea, M. Ward, H. McNulty, A. O’Loughlin, D. M. Collas, C. Tannock, Z. Walker, and C. Katona
- Subjects
Irish ,business.industry ,language ,Library science ,Medicine ,General Medicine ,business ,language.human_language - Published
- 1998
- Full Text
- View/download PDF
15. National scientific medical meeting 1997 abstracts
- Author
-
H. J. Willison, A. J. Lastovica, M. M. Prendergast, A. P. Moran, C. Walsh, I. Flitcroft, P. Eustace, C. McMahon, J. Smith, O. P. Smith, G. Lakshmandass, M. R. H. Taylor, C. V. Holland, D. Cox, B. Good, G. M. Kearns, P. Gaffney, K. Shark, M. Frauenshuh, W. Ortmann, R. Messner, R. King, S. Rich, T. Behrens, N. Mahmud, A. Molloy, J. McPartlin, J. M. Scott, D. G. Weir, K. M. Walsh, D. Thorburn, P. Mills, A. J. Morris, T. Good, S. Cameron, E. A. B. McCruden, M. W. Bennett, J. O’Connell, C. Brady, D. Roche, J. K. Collins, F. Shanahan, G. C. O’Sullivant, M. Henry, S. Koston, K. McMahon, W. MacNee, M. X. FitzGerald, C. M. O’Connor, D. McGonagle, W. Gibbon, P. O’Connor, P. Emery, M. Murphy, R. Watson, E. Casey, E. Naidu, L. Barnes, S. McCann, E. Sweeney, E. J. Barrett, H. Graham, R. T. Cunningham, C. F. Johnston, W. J. Curry, K. D. Buchanan, C. H. Courtney, A. S. McAllister, D. R. McCance, D. R. Hadden, P. M. Bell, H. Leslie, B. Sheridan, A. B. Atkinson, M. T. Kilbane, D. F. Smith, M. J. Murray, S. G. Shering, E. W. M. McDermott, N. J. O’Higgins, P. P. A. Smyth, J. McEneny, E. R. Trimble, I. S. Young, P. Sharpe, C. Mercer, D. McMaster, A. E. Evans, J. Cundick, O. Hasselwander, J. McGeough, D. Savage, A. P. Maxwell, F. Kee, C. J. Larkin, R. G. P. Watson, C. Johnston, J. E. S. Ardill, D. A. McNamara, T. N. Walsh, D. J. Bouchier-Hayes, C. Madden, C. Timon, N. Gardiner, M. Lawler, J. O’Riordan, C. Duggan, S. R. McCann, H. Gowing, E. Braakman, C. Byrne, A. C. M. Martens, A. Hagenbeek, N. Kinsella, S. Cusack, H. Baker, B. White, K. Molloy, A. Wogan, S. McElwaine, D. Hollywood, C. Mcmahon, C. Merry, M. Ryan, O. Smith, F. M. Mulcahy, C. Murphy, J. Briones, P. Lavin, M. McCaffrey, P. Gillen, L. Thompson, M. Lalloz, M. Layton, C. Corish, N. P. Kennedy, P. Flood, S. Mulligan, E. McNamara, P. M. Mathias, E. Ball, D. Duiculescu, P. Calistru, N. O’Gorman, M. Abuzakouk, C. Feighery, M. Brannigan, S. Pender, F. Keeling, J. Varghese, M. Lee, M. Colreavy, R. Gaffney, S. Hone, M. Herzig, M. Walsh, C. Dolan, D. Donovan, J. Harmey, A. Haverty, J. H. Wang, J. H. Harmey, H. P. Redmond, G. McGreal, M. J. Moriarty, A. Shortt, E. Kay, G. Pidgeon, P. Dunne, H. Lambkin, J. M. Russell, A. J. O’Neill, B. M. Dunne, M. O’Donovan, E. F. Gaffney, J. E. Gillan, T. G. Cotter, J. Horan, D. Jones, S. K. Biswas, E. C. Mulkerrin, H. Brady, J. O’Donnell, J. Neary, E. Healy, A. Watson, B. Keogh, C. Cassidy, S. Ward, E. Stokes, F. Keoghan, A. Barrett, P. O’Connell, N. Ryall, P. A. O’Connell, A. Jenkinson, T. O’Brien, P. G. O’Connell, R. Harrison, T. Barrett, D. M. D. Bailey, A. Butler, D. E. Barton, G. Daly, M. Gill, S. Heron, Z. Hawi, M. Fitzgerald, L. Mynett-Johnson, D. Shiels, K. Kendler, P. McKeon, R. Straub, D. Walsh, F. Ryan, D. McCabe, R. Murphy, R. Segurado, T. Mulcahy, B. Larson, C. Comerford, R. O’Connell, E. O’Mahony, J. Donnelly, F. Minahan, D. O’Neill, Z. Farrell, C. Glynn, E. Mulkerrin, S. E. Lennox, A. Murphy, I. M. Rea, H. McNulty, C. McMeel, H. McEvoy, R. Freaney, M. J. McKenna, M. Crowe, D. Keating, G. Norman, S. Widda, L. Viani, null Galvin, C. M. Nolan, O. Hardiman, F. Brett, O. Droogan, P. Gallagher, M. Harmey, M. King, J. Murphy, R. Perryrnan, S. Sukumaran, J. Walsh, M. A. Farrell, G. Hughes, C. Cunningham, J. B. Walsh, D. Coakley, M. Hurson, P. McMonagle, S. O’Sullivan, P. Dodd, J. Redmond, R. Browne, S. Keating, J. O’Connor, B. P. Cassidy, R. Smyth, N. P. Sheppard, R. Cullivan, J. Crown, N. Walsh, A. Denihan, I. Bruce, A. Radic, B. A. Lawlor, P. K. Bridges, M. O’Doherty, A. Farrington, B. Farragher, S. Fahy, R. Kelly, T. Carey, J. Owens, O. Gallagher, D. Sloan, C. McDonough, P. Casey, A. Horgan, A. Elneihum, C. O’Neill, T. McMonagle, J. Quinn, D. Meagher, P. Murphy, A. Kinsella, J. Mullaney, J. L. Waddington, S. Rooney, L. Bamford, J. J. O’Connor, R. Franklin, K. O’Brien, G. Fitzpatrick, J. G. Laffey, J. F. Boylan, J. Laffey, M. Coleman, J. Boylan, A. J. McShane, J. P. R. Loughrey, J. Gardiner, J. McGinley, I. Leonard, M. Carey, P. Neligan, J. O’Rourke, A. Cunningham, F. Fennessy, C. Kelly, D. Bouchier-Hayes, J. Kellett, D. Murphy, J. Regan, D. O’Keeffe, A. Mahmud, L. Hemeryck, J. Feely, M. Hall, I. B. A. Menown, T. P. Mathew, G. S. Nesbitt, M. Syme, A. A. J. Adgey, F. Turtle, J. Allen, J. Anderson, R. O’Hanlon, M. B. Codd, S. Walkin, H. A. McCann, D. D. Sugrue, A. M. Rasheed, G. Chen, A. Leahy, S. Jina, I. McDowell, Q. Wo, M. N. Shuhaibar, E. McGovern, G. Manoharan, R. Kirkpatrick, N. P. S. Campbell, C. McCarthy, Y. Wen, S. Killalea, C. J. Fahy, A. Griffith, A. Fraser, T. Ryan, M. Browne, J. Fenton, J. Hughes, C. I. Timon, A. Curran, D. Smyth, J. P. Hughes, P. Lee, A. Kelly, N. Shine, A. Blayney, D. P. McShane, J. Hussey, M. Howlett, A. Langton, A. McEvoy, J. Slevin, C. Fitzpatrick, M. J. Turner, F. Enright, N. Goggin, C. Costigan, D. Duff, P. Osizlok, F. Wood, R. B. Fitzsimons, N. Flanagan, E. Molloy, E. Griffin, P. F. Deasy, M. Sheridan, M. J. White, R. Moore, A. Gray, J. Hill, J. F. T. Glasgow, B. Middleton, D. Slattery, V. Donoghue, A. McMahon, A. McCarthy, P. Oslislok, I. Keogh, K. J. Russell, M. X. Fitzgerald, P. V. Kavanagh, S. M. McNamara, M. Barry, J. E. O’Brien, P. McCormick, C. Molony, R. M. Doyle, P. R. O’Connell, L. C. Dowey, H. McGlynn, D. I. Thurnham, S. J. Elborn, L. Flynn, J. Carton, B. Byrne, C. O’Farrelly, P. Kelehan, C. O’Herlihy, A. M. O’Hara, A. Orren, B. A. Fernie, S. Clarke, G. Courtney, C. de Gascun, M. Byrne, E. Moylett, H. Murphy, K. Butler, C. Nourse, H. Thaker, C. Barry, J. Russell, G. Sheehan, B. Boyle, R. Hone, B. Conboy, C. Butler, D. Moris, M. Cormican, J. Flynn, O. McCormack, N. Corbally, A. Murray, S. Kirrane, C. O’Keane, S. M. Lynch, B. Cryan, D. Whyte, D. Morris, G. Corbett-Feeney, T. Mackle, J. Perkins, C. Saidlear, A. Young, M. Wrigley, J. Clifford, O. Tighe, D. T. Croke, J. Drago, D. R. Sibley, M. Carvalho, M. Hennessy, M. Kelly, C. Hughes, M. Hanlon, K. Sabra, T. Keane, D. Egan, C. Maerry, S. C. Sharma, D. Williams, N. G. Mahon, G. M. Sayers, and Z. Johnson
- Subjects
Medical education ,business.industry ,Medicine ,General Medicine ,business - Published
- 1998
- Full Text
- View/download PDF
16. Are Newspapers a Viable Source for Intentional Injury Surveillance Data?
- Author
-
Philip R. Fine, Ches S. Jones, J. M. Wrigley, J S Richards, and Matthew D. Rousculp
- Subjects
education.field_of_study ,business.industry ,Population ,Newspapers as Topic ,Poison control ,General Medicine ,Violence ,Criminology ,Social issues ,Suicide prevention ,Occupational safety and health ,Newspaper ,Suicide ,Homicide ,Population Surveillance ,Rape ,Injury prevention ,Alabama ,Humans ,Wounds and Injuries ,Medicine ,education ,business ,Coroners and Medical Examiners - Abstract
Previous researchers have reported that newspapers were useful adjuncts to unintentional injury surveillance efforts in a nearby southern state. The current study sought to determine whether newspaper accounts of intentional injuries could provide a reliable source of primary or secondary surveillance data.Newspaper accounts of assaults, homicides, suicides, and rapes occurring in Jefferson County, Alabama, between January 1, 1991, and December 31, 1991, were compared with similar data from official governmental agencies whose responsibility it is to investigate and/or document the occurrence, details, and characteristics of violent events resulting in death or injury.Newspapers greatly underreported suicides, rapes, and assaults, and reported firearms-related incidents in numbers that substantially exceeded their actual occurrence.Much information of potential value for injury surveillance purposes appears to be excluded from newspapers by editorial process and policy. Thus, newspapers are neither a valid nor reliable source for intentional injury surveillance purposes.
- Published
- 1998
- Full Text
- View/download PDF
17. Factors influencing failure to return to work due to traumatic brain injury
- Author
-
C. M. Branche-Dorsey, Arlene I. Greenspan, Philip R. Fine, J. M. Wrigley, and M. Kresnow
- Subjects
Adult ,Male ,Gerontology ,medicine.medical_specialty ,Adolescent ,Traumatic brain injury ,medicine.medical_treatment ,Population ,Neuroscience (miscellaneous) ,Poison control ,Neuropsychological Tests ,Occupational safety and health ,Disability Evaluation ,Absenteeism ,Activities of Daily Living ,Injury prevention ,Developmental and Educational Psychology ,medicine ,Humans ,Longitudinal Studies ,education ,Retrospective Studies ,education.field_of_study ,Rehabilitation ,business.industry ,Rehabilitation, Vocational ,Length of Stay ,Middle Aged ,medicine.disease ,Functional Independence Measure ,Brain Injuries ,Alabama ,Physical therapy ,Brain Damage, Chronic ,Female ,Neurology (clinical) ,business ,Psychosocial ,Follow-Up Studies - Abstract
About 63% of all traumatic brain injuries (TBI) occur in teenagers and adults aged 15-64 years, the primary working population. Since reports of failure to return to work (FTRTW) vary, understanding the factors that influence FTRTW is key to improving work outcomes for this primarily working-age population. Our study sample consists of 343 previously employed persons who were hospitalized following TBI and had either returned to work at 1 year or had failed to return to work because of their injury (injury-related FTRTW). Medical records were reviewed and participants were interviewed by telephone at 1 year post-discharge. Individuals with injury-related FTRTW were far more likely to report dependence or modified independence on the Functional Independence Measure (FIM) than those who were employed at 1 year. The joint distribution of motor and cognitive items suggests that, for a given level of cognitive function, the addition of a motor limitation will result in greater injury-related FTRTW. In addition as motor function declines, FTRTW is further increased. Injury-related FTRTW is also associated with being unmarried and not completing high school. While the importance of behavioural, economic, and psychosocial factors should not be minimized, services aimed at improving function can be expected to have an impact on RTW after TBI.
- Published
- 1996
- Full Text
- View/download PDF
18. Barriers to return to work among persons unemployed due to arthritis and musculoskeletal disorders
- Author
-
M. B. White, J. M. Wrigley, Richard Maisiak, Philip R. Fine, Karin V. Straaton, and Johnson P
- Subjects
Adult ,Employment ,Male ,medicine.medical_specialty ,Time Factors ,Health Status ,media_common.quotation_subject ,Immunology ,Pain ,Arthritis ,Arthritis, Rheumatoid ,Occupational medicine ,Rheumatology ,Arthropathy ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Musculoskeletal Diseases ,Prospective Studies ,Prospective cohort study ,media_common ,business.industry ,Chronic pain ,Middle Aged ,medicine.disease ,Logistic Models ,Socioeconomic Factors ,Unemployment ,Rheumatoid arthritis ,Physical therapy ,Female ,business ,Disability insurance ,Follow-Up Studies - Abstract
Objective. To identify barriers to return to work (RTW) among persons likely to be seen in a clinician's practice who are unemployed due to arthritis and musculoskeletal disorders. Methods. Two hundred eighteen persons unemployed due to arthritis and musculoskeletal disorders were interviewed at baseline and followed up for 1 year, at which time their work status was ascertained. Backward stepwise logistic regression was used to determine the association of baseline clinical, sociodemographic, and work-related factors to their work status at 1 year of followup. Results. Fifty-one (24%) of 216 initially unemployed subjects had returned to permanent paid employment of ≥20 hours/week after 1 year. Having rheumatoid arthritis, Social Security Disability Insurance (SSDI) status, a high pain level, older age, and lower education were barriers to reemployment. Conclusion. This study establishes the importance of chronic pain and having rheumatoid arthritis as factors independently associated with failure to RTW among persons unemployed due to arthritis and musculoskeletal disorders. The importance of SSDI beneficiary status, age, and education level in RTW is further confirmed. Duration of unemployment or previous work factors were not predictors of RTW in this group.
- Published
- 1996
- Full Text
- View/download PDF
19. National scientific medical meeting 1995 abstracts
- Author
-
S. Norris, C. Collins, J. Hegarty, C. O’Farrelly, J. Carton, L. Madrigal, D. P. O’Donoghue, H. Holloway, J. F. Fielding, W. Mullins, S. W. Hone, M. Donnelly, F. Powell, A. W. Blayney, E. A. Cahill, S. F. Daly, M. J. Turner, P. A. Sullivan, M. McLoughlin, M. M. Skelly, H. E. Mulcahy, T. Connell, C. Duggan, M. J. Duffy, A. Troy, K. Sheahan, A. Whelan, C. M. Herra, C. T. Keane, H. Johnson, B. Lee, E. Doherty, T. McDonnell, D. Mulherin, O. FitzGerald, B. Bresnihan, H. M. Hassett, A. Boyce, V. Greig, C. O’Herlihy, P. P. A. Smyth, E. F. Roche, I. McCormack, E. Tempany, M. J. Cullen, D. F. Smith, Y. McBrinn, B. Murray, R. Freaney, D. Keating, M. J. McKenna, J. A. O’Hare, H. Alam, Q. Raza, M. Geoghegan, S. Killalea, M. Hall, J. Feely, L. Kyne, B. O’Hara, M. Cullen, I. M. Rea, J. P. Donnelly, R. W. Stout, P. Lacey, M. J. Donnelly, J. McGrath, T. P. Hennessy, C. V. I. Timon, D. Hyde, H. X. Xia, M. Buckley, C. O’Morain, S. Keating, H. Xia, J. P. McGrath, R. C. Stuart, P. Lawlor, P. J. Byrne, T. N. Walsh, T. P. J. Hennessy, M. Duffy, M. Tubridy, J. Redmond, K. Monahan, R. P. Murphy, D. R. Headon, T. O’Gorman, F. M. O’Reilly, C. Darby, G. M. Murphy, A. Murphy, M. Codd, P. Dervan, D. Lawlor, S. O. Loughlin, N. Flanagan, R. Watson, L. Barnes, C. Kilgallen, E. Sweeney, A. Mynes, D. Mooney, I. Donoghue, O. Browne, J. A. Kirrane, D. McKenna, M. Young, E. O’Toole, S. O’Briain, U. Srinivasan, C. Feighery, N. Leonard, E. Jones, M. A. Moloney, D. G. Weir, M. Lawler, A. O’Neill, H. Gowing, D. Pamphilon, S. R. McCann, G. O’Toole, A. Orren, C. M. Seifer, D. C. Crowley, G. J. Sheehan, T. Deignan, J. Kelly, V. J. Tormey, J. Faul, C. Leonard, C. M. Burke, L. W. Poulter, S. Lynch, G. McEntee, O. Traynor, E. Barry, P. Costello, A. Keavney, R. Willoughby, C. O’Donnell, M. Cahill, A. Earley, P. Eustace, R. Osborne, C. Saidlear, B. Holmes, A. Early, A. P. Moran, A. Neisser, R. J. Polt, H. Bernheimer, M. Kainz, B. Schwerer, L. Gallagher, R. Firth, N. Kennedy, E. McGilloway, N. Tubridy, K. Shields, W. K. Cullen, M. J. Rowan, A. R. Moore, M. Rowan, D. Coakley, B. Lawlor, G. Swanwick, R. Al-Naeemi, R. Murphy, N. M. Codd, M. Goggins, N. P. Kennedy, B. L. Mallon, H. Mulcahy, M. Skelly, D. O. Donoghue, D. McCarthy, A. Saunders, D. J. Veale, J. J. F. Belch, D. Breathnach, E. Murphy, G. Kernohan, K. Gibson, A. G. Wilson, G. W. Duff, N. de Vries, L. B. A. van de Putte, J. Donoghue, F. O’Kelly, Z. Johnson, T. Maher, A. Moran, C. Keane, D. O’Neill, N. Horgan, J. M. Barragry, D. M. Campbell, M. Behan, P. R. O’Connell, V. S. Donnelly, D. Crowley, M. Geary, P. Boylan, M. Fanagan, K. Hickey, T. Teoh, M. Doyle, R. Harrison, D. Lyons, Y. Shenouda, M. Coughlan, P. McKenna, P. Lenehan, M. Foley, P. Kelehan, P. Ravichandran, M. Kelly, A. Conroy, C. Fitzpatrick, D. Egan, C. L. Regan, B. V. McAdam, P. McParland, G. A. FitzGerald, D. J. Fitzgerald, S. C. Sharma, K. Foran, C. Barry-Kinsella, R. F. Harrison, F. J. Gillespie, P. O’Mahony, M. Boyle, M. J. White, F. Donohoe, Y. Birrane, M. Naughton, R. B. Fitzsimons, M. Piracha, S. McConkey, E. Griffin, E. Hayes, T. Clarke, N. Parfrey, K. Butler, A. J. Malone, P. J. Kearney, P. F. Duggan, A. Lane, R. Keville, M. Turner, S. Barry, D. Sloan, S. Gallagher, M. Darby, P. Galligan, J. Stack, N. Walsh, M. O’Sullivan, M. Fitzgerald, D. Meagher, S. Browne, C. Larkin, P. Casey, E. O’Callaghan, S. Rooney, E. Walsh, M. Morris, T. Burke, M. Roe, C. Maher, M. Wrigley, M. Gill, M. Burgess, E. Corcoran, D. Walsh, B. Gilmer, C. B. Hayes, L. Thornton, J. Fogarty, R. Lyons, M. O’Connor, V. Delaney, K. Buckley, D. Lillis, V. Delany, C. Hayes, P. Dack, D. Igoe, H. J. O’Neill, P. Kelly, D. McKeown, L. Clancy, G. Varghese, S. Hennessy, J. J. Gilmartin, K. Birthistle, D. Carrington, H. Maguire, P. Atkinson, C. Foley-Nolan, M. Lynch, B. Cryan, D. Whyte, C. Conlon, V. Kucinskas, U. Usinskiene, I. Sakalyte, E. Dawson, K. Molloy, N. Goulden, J. Doyle, E. Lawlor, M. G. Harrington, N. El-Nageh, M. -L. Nolan, J. O’Riordan, G. Judge, G. Crotty, T. Finch, M. Borton, T. Barnes, O. Gilligan, G. Lee, R. Limmer, M. Madden, C. Bergin, A. O’Leary, F. Mulcahy, F. Wallis, M. Glennon, M. Cormican, U. NiRiain, M. Heiginbothom, F. Gannon, T. Smith, C. O’Sullivan, R. Hone, D. A. Caugant, C. A. P. Fijen, E. J. Van Schalkwyk, G. J. Coetzee, U. Ni Riain, M. G. Cormican, L. Park, J. Flynn, V. Regazzoli, M. Hayes, G. Nicholson, P. Higgins, N. Flynn, G. Corbett-Feeney, D. J. Conway, N. J. O’Higgins, S. Rajendiran, J. Byrne, E. Kilfeather, P. Dingle, M. Hunter, S. K. Al-Ghazal, P. Stanley, J. Palmer, A. Hong, P. Saxby, D. Sheehan, I. Regan, J. O’Mullane, M. Ni Chaoimh, M. Leahy, J. J. Heffron, M. Lehane, C. Keohane, N. O’Leary, M. Sheehan, E. Renny-Walsh, M. J. Whelton, C. T. Doyle, J. Webster, N. Benjamin, S. FitzGerald, J. S. Chadha, M. G. FitzGerald, G. R. FitzGerald, L. Hemeryck, P. McGettigan, J. Golden, N. Arthur, S. Y. Wen, P. Deegan, T. Cooke, G. I. Adebayo, P. Gaffney, M. Sinnot, D. O’Riordan, T. Hayes, C. M. O’Connor, M. X. FitzGerald, C. Costello, G. Finlay, J. Hayes, C. O’Connor, K. McMahon, S. Hone, J. Robertson, R. Coakley, S. O’Neill, M. Walsh, J. McCarthy, D. Lannon, A. E. Wood, R. Sharkey, E. Mulloy, M. Long, I. Kilgallen, V. Tormey, S. Horne, T. Feeney, Ó. Ó Muiré, M. J. Griffin, D. Hughes, A. Knaggs, D. Magee, C. McCrory, B. March, D. Phelan, M. White, J. Fabry, D. Buggy, C. Cooney, E. Aziz, D. O’Keefe, A. J. McShane, J. Boylan, E. Tobin, C. Motherway, F. Colreavy, N. Denish, R. Dwyer, A. Bergin, K. O’Brien, R. MacSullivan, K. D. Carson, W. P. Blunnie, D. C. Moriarty, B. Kinirons, B. Lyons, N. Cregg, W. Casey, K. P. Moore, S. A. Colbert, C. Ecoffey, D. O’Gorman, J. Fitzgerald, P. Diamond, M. B. Codd, D. D. Sugrue, J. Kellett, M. Tighe, C. J. McKenna, J. Galvin, H. A. McCann, A. Scallon, A. Fraser, M. Norton, G. Tomkin, I. Graham, A. Byrne, M. Maher, N. Moran, D. Fitzgerald, D. O’Callaghan, D. Coyle, A. G. Nugent, C. McGurk, G. D. Johnston, A. Nugent, B. Silke, N. Murphy, L. Jennings, D. Pratico, C. Doyle, T. Hennessy, H. McCann, D. Sugrue, S. Donnelly, A. Hennessy, C. Hartigan, D. MacDonald, S. Blake, D. McDonald, D. Dominque, S. R. McMechan, G. MacKenzie, J. Allen, G. T. Wright, G. J. Dempsey, M. Crawley, J. Anderson, A. A. J. Adgey, M. T. Harbinson, N. P. S. Campbell, C. M. Wilson, P. K. Ellis, E. M. McIlrath, A. McShane, T. V. Keaveny, K. Rabenstein, F. Scheller, D. Pfeiffer, C. Urban, I. Moser, G. Jobst, A. Manz, S. Verpoorte, F. Dempsey, D. Diamond, M. Smyth, E. Dempsey, V. Hamilton, J. Twomey, R. Crowley, L. Fenelon, F. Walsh, J. McCann, P. McDonagh, E. McGovern, D. Luke, K. Crowley, D. Mannion, D. Murphy, K. Clarkson, E. Carton, I. Leonard, D. O’Toole, M. Staunton, M. Griffin, D. Owens, P. Collins, A. Johnson, G. H. Tomkin, N. A. Herity, J. D. Allen, R. O’Moore, G. M. Crotty, M. DeArce, K. Nikookam, P. Keenan, D. Cregan, N. O’Meara, S. Forman, D. A. Cusack, and B. Farrell
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,medicine ,MEDLINE ,General Medicine ,business - Published
- 1995
- Full Text
- View/download PDF
20. Irish Gerontological Society
- Author
-
M. Healy, R. O’Moore, E. M. Keane, D. Coakley, J. B. Walsh, M. Tully, G. Swanwick, R. Coen, I. Bruce, D. O’Mahony, A. Radic, F. O’Kelly, M. O’Doherty, B. A. Lawlor, H. Lee, J. Conway, E. Keane, K. Ng, S. Murphy, K-T. Khaw, H. May, J. E. Compston, H. Taggart, V. Crawford, C. Twomey, L. Delaney, M. Crowley, M. Hyland, V. Hegarty, M. C. Donovan, M. Pye, M. Reardon, P. Coleman, C. M. Hyland, T. Scott, C. T. Keane, B. Farragher, A. O’Connor, E. Quinn, D. Mahony, M. Rowan, F. Buggy, A. Freyne, M. Wrigley, A. P. Passmore, V. L. S. Crawford, T. R. O. Beringer, D. H. Gilmore, A. Hussain, D. Grant, A. Montgomery, L. Hemeryck, P. M. E. McCormack, N. Sheehan, A. Guely, L. Leonard, D. Caulfield, M. Nic Cártaigh, J. Feely, E. Mulkerrin, B. A. Clark, F. H. Epstein, N. Keane, E. McCabe, M. Shepherd, M. J. O’Donnell, R. A. Cooper, M. Nurzaman, R. W. Brooks, S. K. Sinha, D. Kane, M. McKiernan, J. Crowe, J. Lennon, J. Sheehan, M. Rearden, F. Tracey, J. T. Lawson, R. W. Stout, H. Williams, M. Naguib, S. O’Keefe, J. Lavan, S. M. Madigan, H. McNulty, J. Eaton-Evans, J. J. Strain, G. Stanwick, F. Horgan, D. Keating, M. Crowe, A. McNamara, P. Leahy, S. Healy, D. Moraes, J. Tyrell, S. O’Keeffe, R. Glasgow, W. Tormey, P. Finucane, B. K. Nair, C. McCann, R. F. Coen, C. A. O’Boyle, C. R. B. Joyce, B. Hiltbrunner, R. Clarke, and J. Cooney
- Subjects
Irish ,business.industry ,language ,Medicine ,Library science ,General Medicine ,business ,language.human_language - Published
- 1994
- Full Text
- View/download PDF
21. Heterogeneity of red blood cell perfusion in capillary networks supplied by a single arteriole in resting skeletal muscle
- Author
-
Alan C. Groom, Christopher G. Ellis, and S M Wrigley
- Subjects
Erythrocytes ,Time Factors ,Physiology ,Capillary action ,Rest ,Coefficient of variation ,Arteriole ,medicine.artery ,medicine ,Animals ,Mean flow ,Sartorius muscle ,Chemistry ,Muscles ,Rana pipiens ,Anatomy ,Capillaries ,Spatial heterogeneity ,Arterioles ,Red blood cell ,medicine.anatomical_structure ,Regional Blood Flow ,Cardiology and Cardiovascular Medicine ,Perfusion ,Blood Flow Velocity ,Biomedical engineering - Abstract
Flow heterogeneity within capillary beds may have two sources: (1) unequal distribution of red blood cell (RBC) supply among arterioles and (2) unique properties of RBC flow in branching networks of capillaries. Our aim was to investigate the capillary network as a source of both spatial and temporal heterogeneity of RBC flow. Five networks, each supplied by a single arteriole, were studied in frog sartorius muscle (one network per frog) by intravital video microscopy. Simultaneous data on RBC velocity (millimeters per second), lineal density (RBCs per millimeter), and supply rate (RBCs per second) were measured continuously (10 samples per second) from video recordings in 5 to 10 capillary segments per network for 10 minutes by use of automated computer analysis. To quantify heterogeneity, mean values from successive 10-second intervals were tabulated for each flow parameter in each capillary segment (ie, portion of capillary between successive bifurcations), and percent coefficient of variation (SD/mean.100%) was calculated for (1) spatial heterogeneity among vessels (CVs) every 10 seconds and for the entire 10-minute sample and (2) temporal heterogeneity within vessels for every capillary segment and for the mean flow parameter. Analysis of these data indicates that (1) capillary networks are a significant source of both spatial and temporal flow heterogeneity, and (2) continuous redistributions of flow occur within networks, resulting in substantial temporal changes in CVs, although a persistent spatial heterogeneity of perfusion still exists on a 10-minute basis. In most networks, CVs decreased as supply rate within the network increased, thus indicating that rheology plays a significant role in determining the perfusion heterogeneity.
- Published
- 1994
- Full Text
- View/download PDF
22. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study
- Author
-
Peter F. M. Wrigley, Peter Johnson, Marcia Hall, Matthew T. Seymour, and M. L. Slevin
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Injections, Subcutaneous ,Leucovorin ,Alpha interferon ,Neuroendocrine tumors ,Pharmacology ,Adenocarcinoma ,Interferon alpha-2 ,Gastroenterology ,Drug Administration Schedule ,Bolus (medicine) ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Drug Interactions ,Infusions, Intravenous ,Interferon Alpha 2a ,Aged ,Gastrointestinal Neoplasms ,Dose-Response Relationship, Drug ,business.industry ,Interferon-alpha ,Middle Aged ,medicine.disease ,Recombinant Proteins ,Regimen ,Neuroendocrine Tumors ,Oncology ,Fluorouracil ,Toxicity ,Injections, Intravenous ,Neoplasms, Unknown Primary ,Female ,business ,medicine.drug ,Research Article - Abstract
Twenty-nine patients with adenocarcinomas of gastrointestinal or unknown primary, and three with advanced neuroendocrine tumours, were entered into a study of bolus plus infusional 5-fluorouracil (FUra) modulated with high-dose leucovorin (LV) and recombinant interferon alpha 2a (IFN-alpha). Successive cohorts of > or = 4 patients received IFN-alpha at 1.5, 3, 4.5, 6 and 9 MU on alternate days throughout the treatment period. The FUra/LV regimen consisted of: LV 200 mg m-2 i.v. infusion over 2 h, FUra 400 mg m-2 i.v. bolus then FUra 400 mg m-2 i.v. infusion over 22 h, all repeated on day 2, on a 14-day cycle. FUra was given at 75% dose for the first course, increasing (in the absence of WHO grade > or = 2 toxicity) to 87.5% for the second and 100% for subsequent courses up to a maximum of 12. The maximum tolerated dose (MTD) of IFN-alpha was 6 MU on alternate days, with 7/8 patients at 9 MU requiring dose reductions. At 6 MU IFN-alpha, the MTD of FUra was not exceeded at 100% (i.e. 400 mg m-2 bolus and infusion, days 1 and 2), and FUra-related toxicities (mucosal, haematological, dermatological) were extremely mild. Twenty-nine patients were assessable for tumour response, among whom WHO criteria partial responses were seen in 7/14 with colorectal, 1/4 with gastric, 0/1 with pancreatic, 1/3 with neuroendocrine and 3/6 with unknown primaries. Median response duration was 51 weeks. Minor responses and stable disease were seen in a further six patients. Median survival of patients with advanced adenocarcinomas was 9 months, with 33% surviving beyond 18 months. This schedule offers a safe way of co-administering FUra, LV and IFN-alpha. The addition of IFN-alpha, while causing significant independent toxicity, does not significantly increase the dose-limiting mucosal toxicities of FUra/LV. Further investigation is required to determine the contribution of IFN-alpha to the anti-tumour activity of the combination.
- Published
- 1994
23. Irish gerontological society
- Author
-
K-T. Khaw, J. E. Compston, S. Murphy, R. Lawlor, C. McGee, V. Hegarty, T. Scott, M. MacMahon, M. Healy, R. R. O’Moore, C. T. Keane, E. Mulvihill, H. Taggart, V. L. S. Crawford, F. Tracey, V. Crawford, D. O’Mahory, J. Coffey, D. Hamilton, P. Freyne, E. M. Keane, H. Wilson, A. Maher, D. McGrane, J. B. Walsh, D. Coakley, R. F. Coen, D. O’Mahony, C. A. O’Boyle, J. Browne, C. R. B. Joyce, D. O’Neill, G. K. Wilcock, Jane Crossin, J. O. M Mills, J. C. Collins, D. H. Gilmore, T. R. O. Beringer, M. Miller, C. M. Hyland, C. Twomey, E. M. Corcoran, A. Guerandel, M. Wrigley, H. Lee, P. J. Walsh, G. Hickey, J. Tyrrell, C. McCabe, E. Kelly, G. Swanwick, F. Ward, B. A. Lawlor, D. Moraes, P. M. E. McCormack, J. Feely, S. V. Jassal, S. C. Coulshed, J. F. Douglas, R. W. Stout, Nuala Kane, N. Keane, B. Brennan, S. Denholm, J. Fox, E. Herlihey, S. O’Keeffe, J. Noel, J. Lavan, S. Mclntosh, R. A. Kenny, J. Lawson, D. da Costa, G. Ford, E. Mulkerin, K. Rice, E. A. Freeman, C. B. Keyes, A. Hickey, D. Clinch, R. Liston, A. P. Passmore, C. M. Passmore, S. Copeland, R. W. tout, and G. D. Johnston
- Subjects
Spine (zoology) ,Bone mineral ,business.industry ,Medicine ,Dentistry ,General Medicine ,business ,Body mass index - Published
- 1993
- Full Text
- View/download PDF
24. Patterns of survival in patients with Hodgkin's disease: Long follow up in a single centre
- Author
-
Walter M Gregory, J. A. L. Amess, L. Dadiotis, V. Barbounis, T. A. Lister, Peter F. M. Wrigley, A. M. Oza, J. Lim, A. G. Stansfeld, Arthur Jones, Trivadi S. Ganesan, M. Leahy, and A. Z. S. Rohatiner
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Median follow-up ,Humans ,Medicine ,Combined Modality Therapy ,Aged ,Chemotherapy ,business.industry ,Remission Induction ,Neoplasms, Second Primary ,Hematology ,Middle Aged ,medicine.disease ,Hodgkin Disease ,Chemotherapy regimen ,Surgery ,Lymphoma ,Survival Rate ,Radiation therapy ,Oncology ,Localized disease ,Female ,Neoplasm Recurrence, Local ,business ,Progressive disease ,Follow-Up Studies - Abstract
BACKGROUND Prolonged remission can now be induced in the majority of patients with Hodgkin's disease with chemotherapy and/or irradiation. However, there is a significant proportion of patients in whom this approach fails, either at presentation or subsequently. Survival is the definitive endpoint to assess treatment efficacy. In this study, the survival patterns of a large group of consecutive patients treated in a single institution are presented. RESULTS The overall median survival was 18.3 years. Clinical remission (complete remission plus good partial remission) was induced in 443 (85%); the median survival of patients in remission has not been reached. Fifty-eight patients achieved responses less than clinical remission with initial therapy (partial response) or had progressive disease, the median survival of this group being 1.4 years. With further therapy, remission was subsequently induced in 10; 5 are still alive, 5 have died between 1.9 years and 14.3 years. Twenty patients died before completion of therapy. Recurrence has been documented in 147 of the patients in remission (following initial therapy) over a median follow up period of 13 years (minimum 5 years). One hundred forty-three of these patients were retreated following recurrence (105 chemotherapy, 28 radiotherapy, 6 combined modality treatment and 4 surgery). Second remission was induced in 109/143 (76%). There was a trend towards better second remission induction in patients whose first remission was longer than 1 year (p = 0.06). The median duration of second remission was inferior to first remission duration (p < 0.001). There was no correlation between duration of first remission and survival following recurrence (p = 0.8) or with duration of second remission (p = 0.54). There was no significant difference in duration of second remission between patients who were initially treated with radiotherapy or chemotherapy (p = 0.3). The median survival following second remission was 12.0 years, being the same for patients with initially localized disease (stages I and II) treated with radiation alone and for patients with advanced Hodgkin's disease (stages III and IV) treated with chemotherapy. Survival after recurrence is significantly better for patients under 50 years at the time of recurrence (p < 0.001). Second recurrence was documented in 46 patients, third remission being reinduced in 22, the median survival of the latter being 5.1 years. CONCLUSION These results illustrate the importance of prolonged follow up in defining the clinical course of patients with HD and are vital for planning experimental chemotherapy at the time of treatment failure or recurrence.
- Published
- 1993
- Full Text
- View/download PDF
25. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer
- Author
-
M. Butcher, Peter F. M. Wrigley, Peter Johnson, S. Love, S. P. Joel, L. Squires, M. L. Slevin, and M. R. Pandian
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,endocrine system ,Lung Neoplasms ,medicine.medical_treatment ,Gastroenterology ,chemistry.chemical_compound ,Carcinoembryonic antigen ,Predictive Value of Tests ,Recurrence ,Internal medicine ,Lactate dehydrogenase ,medicine ,Carcinoma ,Biomarkers, Tumor ,Chromogranins ,Humans ,Carcinoma, Small Cell ,Etoposide ,Aged ,Chemotherapy ,Analysis of Variance ,Performance status ,biology ,L-Lactate Dehydrogenase ,business.industry ,Respiratory disease ,Middle Aged ,medicine.disease ,Prognosis ,Surgery ,Carcinoembryonic Antigen ,Oncology ,chemistry ,Predictive value of tests ,Phosphopyruvate Hydratase ,biology.protein ,Chromogranin A ,Female ,business ,medicine.drug ,Research Article - Abstract
Levels of the tumour markers neurone specific enolase (NSE), lactate dehydrogenase (LDH), chromogranin A (ChrA) and carcinoembryonic antigen (CEA) were measured in serum taken at presentation and during treatment, remission and relapse from 154 patients who received chemotherapy for small cell lung cancer at a single centre over a 6 year period. At presentation NSE was the most frequently elevated marker, being raised in 81% of patients and significantly higher in extensive as opposed to limited disease, as were LDH and ChrA. The response rate to therapy was best correlated with presentation level of ChrA, being 79% for those whose levels were within twice the upper limit of normal and 51% above (P < 0.01). Multivariate regression analysis showed NSE, performance status and albumin at presentation to be the best independent predictors of survival. Patients with NSE below twice the upper limit of normal, Karnofsky performance status of 80 or above and albumin 35 g l-1 or above had a median survival of 15 months with 25% alive at 2 years, whilst those with NSE above twice normal, Karnofsky below 80 and albumin less that 35 g l-1 had all died by 8 months. Changes in marker levels during therapy were of low predictive value for outcome although the finding of rising NSE during chemotherapy after an initial fall correlated with significantly reduced duration of remission. There was a strong inverse correlation between the NSE level at the time of response and duration of remission (P < 0.0001). Prediction of relapse was most reliable with ChrA, 52% of patients having rising levels before clinical evidence of disease recurrence.
- Published
- 1993
26. Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital
- Author
-
W. S. Shand, T. A. Lister, S. Arnott, N. Perry, Peter F. M. Wrigley, Trivadi S. Ganesan, J. D'Ardenne, A. M. Oza, and A. G. Stansfeld
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Prednisolone ,medicine.medical_treatment ,Diaphragm ,Vinblastine ,Procarbazine ,Mediastinal Neoplasms ,Bleomycin ,Median follow-up ,Prednisone ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Medicine ,Combined Modality Therapy ,Mechlorethamine ,Stage (cooking) ,Lymphatic Diseases ,Aged ,Etoposide ,Neoplasm Staging ,business.industry ,Neoplasms, Second Primary ,Radiotherapy Dosage ,Hematology ,Middle Aged ,Prognosis ,Hodgkin Disease ,Chemotherapy regimen ,Surgery ,Dacarbazine ,Radiation therapy ,Oncology ,Doxorubicin ,Vincristine ,Female ,business ,medicine.drug - Abstract
One hundred seventy-seven consecutive patients with newly diagnosed stage II Hodgkin's disease (HD) (supradragmatic 157; infra diaphragmatic 20) were treated at St. Bartholomew's Hospital on the basis of pathologic stage (PS) in 84 (IIA 69; IIB 15) and clinical stage (CS) in 93 (IIA 33, IIB 60) between January 1968 and December 1984. The median follow up is 13 years. Overall, complete remission (CR) was achieved in 143 patients (75%) of whom 53 have had a recurrence. One hundred twenty-seven patients remain alive, the cumulative predicted survival at 15 yrs being 70%. Mantle radiotherapy was prescribed to 88 patients with supradiaphragmatic HD, of whom 75 entered CR and 9 achieved good partial remission (GPR) (95%). The duration of remission correlated strongly with ESR (greater than 50 mm/h) and mediastinal thoracic ratio (less than 33% vs. greater than 33%) in a multivariate analysis (p = 0.05 and 0.02, respectively). 46/88 patients remain in continuous first remission, the median duration of remission having not reached at 15 years. Combined modality therapy or chemotherapy alone was prescribed to 69 patients with supradiaphragmatic HD, CR being achieved in 51 patients and GPR in 8 at the completion of all therapy. 48/59 patients continue in first remission. The duration of remission of patients receiving combined modality therapy or CT alone was significantly longer (p = 0.002) than that of patients receiving RT alone, in spite of the fact that the former group comprised predominantly of patients with unfavourable features.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1992
- Full Text
- View/download PDF
27. A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence
- Author
-
Chris Frampton, Peter J. Gilling, Andre M. Westenberg, Mark R. Fraundorfer, Liam C. Wilson, Deborah F. Bell, William J. McAllister, Patricia M. Wrigley, and Katie M. Kennett
- Subjects
Nephrology ,medicine.medical_specialty ,Stress incontinence ,Urology ,Magnetic Field Therapy ,Urinary Incontinence, Stress ,Urinary incontinence ,Electric Stimulation Therapy ,Incontinence pads ,Pelvic Floor Muscle ,Extracorporeal ,law.invention ,Randomized controlled trial ,Double-Blind Method ,law ,Internal medicine ,Incontinence Pads ,Medicine ,Humans ,Analysis of Variance ,Pelvic floor ,business.industry ,Pelvic Floor ,Middle Aged ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Treatment Outcome ,Anesthesia ,Female ,medicine.symptom ,business ,Muscle Contraction - Abstract
OBJECTIVE To compare the efficacy of extracorporeal electromagnetic stimulation (ES) of the pelvic floor for treating stress urinary incontinence (SUI) vs sham ES. PATIENTS AND METHODS In all, 70 women with urodynamically confirmed SUI were randomized to receive active (35) or sham (35) ES. The NeoControl chair (NeoTonus, Marietta, GA, USA) was used, and treatment consisted of three sessions per week for 6 weeks. data were collected before and after treatment on all women, including a 20-min provocative pad-test with a predetermined bladder volume (primary outcome measure), a 3-day bladder diary and 24 h pad-test. Circumvaginal muscle (CVM) rating score, perineometry using two separate instruments and video-urodynamics were also used, and the Urinary Incontinence Quality of Life Scale (I-QOL) and King’s Health Questionnaires. Patients were fully re-evaluated 8 weeks after treatment, and the bladder diary, pad-test and questionnaires were repeated at 6 months. The urotherapist and physician were unaware to which treatment group the patient was assigned. RESULTS In the overall group of 70 patients there were significant improvements in each of the primary and secondary outcome measures at 8 weeks. There were also significant improvements in primary and secondary outcome measures in the active treatment group when compared with baseline measures. At 8 weeks, there were improvements in the mean (sd) values for the 20-min pad-test, of 39.5 (5.1) vs 19.4 (4.6) g (P
- Published
- 2009
28. Cancer Mortality, Aging, and Patterns of Comorbidity in the United States: 1968 to 1986
- Author
-
Harvey J. Cohen, Kenneth G. Manton, Max A. Woodbury, and J M Wrigley
- Subjects
Aged, 80 and over ,Cancer mortality ,High rate ,Aging ,Cancer Death Rate ,business.industry ,Age Factors ,Cancer ,Comorbidity ,Middle Aged ,medicine.disease ,United States ,Chronic disease ,Cause of Death ,Neoplasms ,Life expectancy ,medicine ,Humans ,business ,Aged ,Demography ,Cause of death - Abstract
Cancer is often reported as contributing to the risk of noncancer causes of death. The age variation of these reports was studied using U.S. data on all causes of death listed on death certificates for 1968 to 1986. The occurrence of cancer as a nonunderlying cause of death increased with age and was higher for treatable and slowly growing tumor types. These patterns persisted even if the cancer manifested changes in occurrence. Nonunderlying occurrences were highest in the 85 to 94 age group and were correlated with cancer survival. This suggests increased importance of cancer as a cause of death and a comorbid condition among oldest-old persons. The high rate of occurrence as an associated cause of death suggests that if life expectancy increases due to declines in circulatory and other chronic disease mortality, cancer could become the preeminent cause of death in the United States.
- Published
- 1991
- Full Text
- View/download PDF
29. Multivariate Procedures to Describe Clinical Staging of Melanoma
- Author
-
J M Wrigley, Kenneth G. Manton, Max A. Woodbury, and Harvey J. Cohen
- Subjects
Advanced and Specialized Nursing ,Oncology ,Multivariate statistics ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Melanoma ,Population ,Health Informatics ,Disease ,medicine.disease ,Regression ,Term (time) ,Health Information Management ,Internal medicine ,medicine ,Stage I melanoma ,business ,education ,Cluster analysis - Abstract
Analyzing multivariate clinical data to identify subclasses of patients being treated for a specific disease may improve patient management and increase understanding of the behavior of disease under clinical conditions. In some cases, patients have been classified on prognostic characteristics using standard risk assessment procedures (e.g.. Cox’ regression). This requires long term follow-up, differentiates patients only on attributes relevant to survival, and assumes that patients are sampled from a common population. Other approaches involve the use of clustering algorithms to classify patients into categories based on multiple clinical attributes. We illustrate the use of a multivariate statistical procedure to directly characterize patients on multiple clinical characteristics. The procedure is designed to analyze discrete response data with parameters representing individual differences within groups. Its use is illustrated for patients with Stage I melanoma in determining how age is related to treatment response in different patient groups.
- Published
- 1991
- Full Text
- View/download PDF
30. Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital
- Author
-
Trivadi S. Ganesan, T. A. Lister, W. S. Shand, A. J. D'ardenne, Peter F. M. Wrigley, P. A. Murray, A. G. Stansfeld, Arthur Jones, J. S. Malpas, and S. Arnott
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Pathological staging ,medicine ,Humans ,Stage (cooking) ,Lymph node ,Aged ,Neoplasm Staging ,Actuarial Analysis ,Chemotherapy ,business.industry ,Lymphography ,Mediastinum ,Radiotherapy Dosage ,Middle Aged ,Hodgkin Disease ,Surgery ,Radiation therapy ,Axilla ,medicine.anatomical_structure ,Oncology ,Female ,Tomography, X-Ray Computed ,business ,Research Article - Abstract
One hundred and one consecutive patients with newly diagnosed stage I Hodgkin's disease (HD) received treatment at St Bartholomew's Hospital, between 1968 and 1987, with a median follow-up of 12 years. Eleven patients have been excluded from detailed analysis because they either received involved field radiotherapy (RT) or radiotherapy with chemotherapy or were lost to follow-up. Actuarial analysis predicts 78% to be alive and without relapse of Hodgkin's disease at 15 years. Ninety evaluable patients (clinical stage (CS) 24; pathological stage (PS) 66) received either mantle or inverted 'Y' RT and form the basis of this analysis. The median age was 33 years (63 men, 27 women). Histology at presentation was nodular sclerosing (39), lymphocytic predominant (27) or mixed cellularity (24). The presenting site was neck (78), axilla (6) groin (4) and mediastinum (2). Complete remission was achieved in all evaluable patients, the actuarial proportion in remission being 75% at 15 years. Factors predictive of a prolonged remission were pathological staging versus clinical staging (P = 0.02) and lymph node size less than 3 cm (P = 0.04). Actuarial overall survival in these 90 patients was 75% at 15 years and none of the above factors correlated with survival. Relapse of HD has occurred in 18 patients (5 within RT field, 10 without and 3 in both). Second remission was achieved in 15/18. The actuarial rate of second remission and survival was 40% at 10 years. Sixteen patients have died, 7 of Hodgkin's disease, 7 of unrelated causes and 2 of second malignancy. A further 3 patients who developed second malignancy are still alive. At 15 years the actuarial mortality related to HD was 12%. These results confirm the importance of long follow up to assess the efficacy of primary therapy.
- Published
- 1990
- Full Text
- View/download PDF
31. The Sparklet carbon dioxide Resuscitator
- Author
-
P. Nandi and M. Wrigley
- Subjects
Resuscitator ,medicine.medical_specialty ,Resuscitation ,Waste management ,business.industry ,Carbon Dioxide ,History, 20th Century ,Respiration Disorders ,chemistry.chemical_compound ,Anesthesiology and Pain Medicine ,chemistry ,Carbon dioxide ,medicine ,Humans ,Intensive care medicine ,business - Abstract
The use of carbon dioxide in resuscitation was advocated in the 1920s and 1930s. A device, the Sparklet Resuscitator, was marketed to allow the administration of carbon dioxide gas. This piece of equipment is described and the indications for its use in resuscitation reviewed. The use of carbon dioxide appeared to have a degree of support and success as a 'universal' aid to resuscitation.
- Published
- 1994
- Full Text
- View/download PDF
32. Older people and their pets: a f inal farewell
- Author
-
M. Wrigley, C. A. Lynch, O. Hally, and R. Loane
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Animal-assisted therapy ,Suicide attempted ,Human animal bond ,Psychiatry and Mental health ,Pet therapy ,Animal welfare ,Family medicine ,medicine ,HUBzero ,Geriatrics and Gerontology ,Older people ,business ,Clinical psychology - Published
- 2010
- Full Text
- View/download PDF
33. Decrease of Salmonella typhimurium in Skim Milk and Egg by Heat and Ultrasonic Wave Treatment
- Author
-
Dorothy M. Wrigley and Natalie G. Llorca
- Subjects
Salmonella ,food.ingredient ,Dependent manner ,Biology ,biology.organism_classification ,medicine.disease_cause ,Microbiology ,Enterobacteriaceae ,Whole egg ,food ,Skimmed milk ,medicine ,Ultrasonic sensor ,Food science ,Bacteria ,Food Science ,Brain-heart Infusion broth - Abstract
Ultrasonic waves induce cavitation which is lethal for many bacteria. When Salmonella typhimurium was suspended in skim milk or brain heart infusion broth and placed in an ultrasonicating water bath, the number of bacteria decreased by 2 to 3 log CFU in a time dependent manner. The killing by ultrasonic waves was enhanced if the menstruum was simultaneously maintained at 50°C. Ultrasonic reduction in S. typhimurium numbers in liquid whole egg ranged from 1-3 log CFU at 50°C. The results indicate that indirect ultrasonic wave treatment is effective in killing Salmonella in some foods.
- Published
- 1992
- Full Text
- View/download PDF
34. Indomethacin and Protein Binding of Methotrexate
- Author
-
Maurice L. Slevin, Paul Turner, Mark J. Caulfield, S. M. L. Abrams, Peter F. M. Wrigley, Mary Lawson, W. M. Heybroek, and R. Raveendran
- Subjects
Adult ,0301 basic medicine ,Drug ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Indomethacin ,Plasma protein binding ,Pharmacology ,Toxicology ,030226 pharmacology & pharmacy ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,medicine ,Humans ,Drug Interactions ,Aged ,media_common ,business.industry ,Albumin ,Blood Proteins ,General Medicine ,Middle Aged ,Drug interaction ,Blood proteins ,Methotrexate ,030104 developmental biology ,Mechanism of action ,Toxicity ,medicine.symptom ,business ,Protein Binding ,medicine.drug - Abstract
Indomethacin, a non-steroidal anti-inflammatory drug is known to increase the efficacy and toxicity of methotrexate, the widely used anti-cancer drug in man. The mechanism for this interaction has not been clearly established. However, since these drugs bind with albumin, a possible displacement of methotrexate by indomethacin from albumin might explain this interaction. To investigate the possible interaction an in-vitro protein-binding displacement study was carried out in 17 normal volunteers and in two groups of eight cancer patients. One group of patients had active disease and the other was in complete clinical remission. Serum samples were obtained and protein levels estimated. The protein binding of methotrexate was measured alone and with indomethacin using equilibrium dialysis. Statistical analysis of results suggested that the binding of methotrexate is not influenced by indomethacin, confirming that methotrexate is not displaced by indomethacin.
- Published
- 1992
- Full Text
- View/download PDF
35. Qualite di, qualite la, mais surtout le bon conseil!
- Author
-
M. Wrigley
- Published
- 1999
- Full Text
- View/download PDF
36. Phase II trial of UFT in advanced colorectal and gastric cancer
- Author
-
D C Talbot, R. Osborne, Maurice L. Slevin, Rodney H. Reznek, P. I. Clarke, Peter F. M. Wrigley, and S. T. A. Malik
- Subjects
Adult ,Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Colorectal cancer ,Rectum ,Tegafur ,Stomach Neoplasms ,Oral administration ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Medicine ,Uracil ,Aged ,business.industry ,Stomach ,Cancer ,Middle Aged ,medicine.disease ,Confidence interval ,medicine.anatomical_structure ,Fluorouracil ,Drug Evaluation ,Female ,Colorectal Neoplasms ,business ,Research Article ,medicine.drug - Abstract
A phase II trial of continuous oral therapy with UFT, a combination of uracil and the 5-fluorouracil analogue 1-(2-tetrahydrofuryl)-5-fluorouracil (Futraful, Ftorafur), was conducted in 40 patients with advanced colorectal cancer and 18 patients with advanced gastric cancer. Six partial responses were seen in the 36 evaluable patients with colorectal cancer (response rate 16.6%; 95% confidence limits 6.4-32.8%), and one partial response was seen in the 16 evaluable patients with gastric cancer (response rate 6%; 95% confidence limits 0.27-30.2%). The overall toxicity of the treatment was low, and all patients were treated as outpatients. The results suggest that oral UFT has comparable activity to standard regimes of 5-fluorouracil, and because of the convenience of oral administration is a useful therapy in the management of patients with advanced colorectal cancer.
- Published
- 1990
- Full Text
- View/download PDF
37. Factors associated with life satisfaction among a sample of persons with neurotrauma
- Author
-
L, Warren, J M, Wrigley, W C, Yoels, and P R, Fine
- Subjects
Adult ,Male ,Adolescent ,Middle Aged ,Prognosis ,Sampling Studies ,Patient Satisfaction ,Brain Injuries ,Activities of Daily Living ,Quality of Life ,Humans ,Regression Analysis ,Female ,Longitudinal Studies ,Spinal Cord Injuries ,Aged - Abstract
Factors were examined that are associated with life satisfaction one year post-discharge for persons with a spinal cord (SCI) or traumatic brain injury (TBI). Findings show persons with SCI or TBI should be considered as two distinct groups with regard to factors affecting life satisfaction. Different strategies might be considered to affect either group. Three psychosocial variables significantly increased life satisfaction for persons with SCI: closeness to family, the level of family activities, and blaming oneself for the injury. For persons with TBI, total family satisfaction, blaming oneself for the injury, being employed, being married, and having memory and bowel independence significantly increased life satisfaction. For persons with TBI, there was a difference in the number of factors affecting life satisfaction dependent on whether the persons blamed themselves or not. Those who do not blame themselves show a greater number of functional activities as indicators for their self-satisfaction.
- Published
- 1996
38. Factors relating to return to work after burn injury
- Author
-
B K Trotman, Philip R. Fine, Alan R. Dimick, and M Wrigley
- Subjects
Adult ,Male ,medicine.medical_specialty ,Burn injury ,Work ,Multivariate analysis ,Return to work ,Injury Severity Score ,Quality of life ,Risk Factors ,Acute care ,Epidemiology ,Absenteeism ,medicine ,Humans ,General Nursing ,Probability ,Motivation ,business.industry ,Rehabilitation ,Logistic Models ,Socioeconomic Factors ,General Health Professions ,Multivariate Analysis ,Emergency Medicine ,Physical therapy ,Quality of Life ,Surgery ,Female ,business ,Burns ,Demography - Abstract
This study examined the influence of various factors on the probability that 225 persons with severe burns would return to work 12 months after being discharged from the acute care setting. By use of multivariate analysis, 4 out of 15 variables significantly increased the probability of being employed: (1) being white, (2) not blaming oneself, (3) receiving workmen's compensation, and (4) being employed before the injury. With controls for burn severity and other variables, premorbid employment accounted for a person being 171 times more likely to return to work than one who was not employed before injury. Our findings suggest that some traditionally held impressions regarding factors related to return to work after a severe burn should be revisited. Moreover, despite earlier reports concluding that burn severity was the primary predictor of return to work, we found no factors in the acute care environment or patient characteristics that were statistically significant. Instead, findings from this series underscore the importance of the preinjury environment--especially being employed at the time of injury--as the strongest predictor of return to work after a severe burn.
- Published
- 1995
39. Musculoskeletal disability, employment, and rehabilitation
- Author
-
K V, Straaton, R, Maisiak, J M, Wrigley, and P R, Fine
- Subjects
Adult ,Employment ,Male ,Insurance, Health ,Rehabilitation, Vocational ,Middle Aged ,Models, Theoretical ,Medicare ,United States ,Education ,Humans ,Regression Analysis ,Workers' Compensation ,Disabled Persons ,Female ,Musculoskeletal Diseases ,Information Systems - Abstract
To determine which, if any, baseline social and disease characteristics can be used to identify persons with musculoskeletal disabilities accepted for state-federal vocational rehabilitation services who are most likely to return to work.A database of case closures from the Alabama Vocational Rehabilitation Service was analyzed using segmentation modelling. This included all persons (n = 4093) with musculoskeletal disability who were accepted by the Alabama Vocational Rehabilitation Agency in 1987-91. Demographics, income, type of disability, severity of disability, medical insurance, similar benefits, benefit status, and referral source were independent variables. Outcome (dependent) variable was work status at end of agency services.Overall, 71% of persons with arthritis and musculoskeletal disorders who were accepted for vocational rehabilitation services in 1987-91 returned to work at the end of agency services. Segmentation modelling created a tree in which certain baseline characteristics formed subgroups with differing rates of successful rehabilitation. Social Security Disability Insurance (SSDI) status was the single best predictor of rehabilitation. Seventy-three percent of nonbeneficiaries were rehabilitated compared to 55% of beneficiaries (p0.00001). For non-SSDI beneficiaries, education levelor = grade 12 was associated with better rehabilitation outcome (p0.00001). SSDI beneficiaries with nonback disorders fared better than those with back disorders (p0.05). Disease severity, assessed by Federal Special Programs criteria, was not associated with rehabilitation outcome at any level of the tree.Simple baseline social and disease characteristics can be used to identify groups of persons accepted for vocational rehabilitation services with musculoskeletal disability with differing rates of vocational rehabilitation. Disability benefit status and education level are important predictors of return to work after agency services. These findings can lead to the development of strategies to improve the efficacy of vocational rehabilitation services.
- Published
- 1995
40. Late paraphrenia
- Author
-
M A, Gannon and M, Wrigley
- Subjects
Paranoid Disorders ,Depressive Disorder, Major ,Social Isolation ,Humans ,Hearing Disorders ,Aged ,Personality - Abstract
Late paraphrenia is one of a group of paranoid disorders arising in the elderly. The distinctive clinical and social features of this disorder are highlighted in this article together with the possible aetiological causes.
- Published
- 1995
41. Constructed selves, constructed lives: a cultural constructivist perspective of mental health nursing practice
- Author
-
K. M. Wrigley
- Subjects
Ethnopsychology ,media_common.quotation_subject ,Self-concept ,Psychiatric Nursing ,Cultural system ,Mental health ,Self Concept ,Constructivism (philosophy of education) ,Pedagogy ,Rhetorical question ,Humans ,Moral responsibility ,Sociology ,Ideology ,Models, Nursing ,Pshychiatric Mental Health ,Nurse-Patient Relations ,Social psychology ,media_common - Abstract
This paper is an analysis of the position that cultural constructivism is significant to the well-being of psychiatric and mental health discourse and practice. It focusses particularly on the nature of the 'self' as it is perceived from a Western ethnopsychological perspective. Differentiation is made between types of self which can be found in other cultural systems, both within and without Western society. A relationship is explored between the particular definition of the 'self' and discourses on therapeutic relationships, both fundamental tenets of modern mental health nursing practice. This analysis suggests that nurses should endeavour to move beyond the rhetorical, and thus constraining, ideology of individual responsibility, with which mental health practice is now engaged, and move to a basis for practice which depends on understanding clients' lived experiences.
- Published
- 1995
42. Alcohol related problems in elderly people--a prospective study
- Author
-
B, Farragher, M, Wrigley, and R, Veluri
- Subjects
Male ,Alcoholism ,Mental Disorders ,Humans ,Female ,Prospective Studies ,Aged - Abstract
Alcohol related problems in elderly people are often difficult to diagnose because of denial and non specific presentation in this age group. This study examines the factors related to alcohol abuse in elderly people referred to a psychiatry of old age service over a six month period. Patients were specifically screened for alcohol related psychiatric, physical and social problems. Of the 150 patients referred, 23 (15%) had alcohol related problems, with 12 (52%) denying any history of alcohol abuse/dependence. The majority were female (15/23, 65%), of which 10 were late-onset drinkers. Loneliness was found to be a contributory factor in 10 (43%) patients. A large proportion of patients had physical, psychiatric and social problems related to alcohol. Twenty one patients (91%) required psychiatric follow-up. In conclusion, this study confirms elderly peoples vulnerability to the destructive effects of alcohol.
- Published
- 1994
43. A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity
- Author
-
Peter F. M. Wrigley, Rodney H. Reznek, P I Clark, D. I. Talbot, Peter Johnson, T. Masud, S. P. Joel, R. Osborne, Walter M Gregory, and Maurice L. Slevin
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Randomization ,Lung Neoplasms ,medicine.medical_treatment ,Gastroenterology ,Drug Administration Schedule ,law.invention ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Carcinoma, Small Cell ,Lung cancer ,Etoposide ,Aged ,Chemotherapy ,business.industry ,Middle Aged ,medicine.disease ,Survival Analysis ,Carboplatin ,Surgery ,Clinical trial ,Regimen ,Treatment Outcome ,Oncology ,chemistry ,Regression Analysis ,Female ,business ,medicine.drug - Abstract
PURPOSE Etoposide is a schedule-dependent drug, as demonstrated by the superiority of 5 consecutive daily infusions over a continuous 24-hour infusion in patients with small-cell lung cancer. A randomized trial has therefore been conducted to compare an extended 8-day regimen with the 5-day schedule. PATIENTS AND METHODS Ninety-four patients with small-cell lung cancer (35 limited disease, 59 extensive disease) were randomized to receive single-agent etoposide 500 mg/m2, either as 5 daily 2-hour infusions of 100 mg/m2 or as 8 daily 75-minute infusions of 62.5 mg/m2, both repeated every 3 weeks for six cycles. Single-agent carboplatin was administered at relapse in both arms of the study. Patients were stratified at randomization according to extent of disease and Karnofsky performance status (KPS). RESULTS The overall response rate was 81% in the 5-day arm and 87% in the 8-day arm, with median survival durations of 7.1 and 9.4 months, respectively (no significant differences). The time over which plasma etoposide exceeded low plasma concentrations was significantly longer in patients who responded compared with patients who did not respond. This was most significant for time at concentrations greater than 1, 1.5, and 2 micrograms/mL. Hematologic toxicity was significantly worse in the 5-day arm of the study (cycle no. 1 nadir neutrophil count, 0.8 x 10(9)/L v 1.7 x 10(9)/L). Stepwise regression analysis found duration of exposure to plasma etoposide greater than 3 micrograms/mL to be predictive of nadir neutrophil count and duration of exposure to plasma etoposide greater than 2 micrograms/mL to be predictive of nadir WBC count. CONCLUSION The 5-day and 8-day regimens had equivalent activity in small-cell lung cancer. A pharmacokinetic association between concentrations of etoposide and response and toxicity was found. Antitumor activity was associated with the maintenance of lower levels of etoposide than found to be associated with hematologic toxicity. This supports the hypothesis that the schedule of etoposide administration may affect efficacy and toxicity, and that prolonged exposure to low concentrations of etoposide may improve the therapeutic ratio for this drug.
- Published
- 1994
44. Delusional infestation in an elderly population
- Author
-
A, Freyne and M, Wrigley
- Subjects
Aged, 80 and over ,Male ,Parasitic Diseases ,Humans ,Female ,Delusions ,Aged - Abstract
The clinical features of delusional infestation are outlined and six elderly patients who presented with this condition are described. Their presentation and clinical features are discussed in relation to other case reports. Management issues, particularly in relation to aetiology, are outlined.
- Published
- 1994
45. Homicide among black males in Jefferson County, Alabama 1978-1989
- Author
-
P R, Fine, J M, Roseman, C M, Constandinou, R M, Brissie, J M, Glass, and J M, Wrigley
- Subjects
Adult ,Male ,Time Factors ,Adolescent ,Alcohol Drinking ,Infant, Newborn ,Infant ,Middle Aged ,White People ,Black or African American ,Age Distribution ,Cross-Sectional Studies ,Child, Preschool ,Alabama ,Humans ,Female ,Child ,Homicide ,Aged - Abstract
This study examined 1505 of 1573 (96%) homicides occurring in Jefferson County, Alabama, between 1978 and 1989, that were investigated by the Coroner/Medical Examiners' Office. During this 12 year period, Jefferson County's average annual homicide rate was 18.9 per 100,000 compared to an 11.3 per 100,000 State of Alabama's rate and a 9.3 per 100,000 US rate. In Jefferson County, the average annual homicide rate among blacks (41.4) was almost six times the rate among whites (7.1). The highest average annual race-specific homicide rate was in black males (75.9), followed by black females (12.4), white males (10.4) and white females (4.1). Black males in the 25-34 year age group had the highest rate (159.7), followed by black males in the 35-44 year age group (151.7) and then by black males in the 15-24 year age group (96.2). These rates ranged from almost eight to over eleven times the rates of similarly aged, black females or white males and were over 33 times higher than the rates for white females of the same age. Our results emphasize the high rates of black male on black male violence, the acquaintance of the black male victim and perpetrator, and the importance of arguments as an inciting event. Moreover, we determined that while the raw numbers and rates for black homicides were and are staggering, the average annual homicide rate for black males was actually declining at a greater rate than for all other race-sex groups. Further, our results suggest that a number of hypothesized determinants commonly believed to be associated with the increase in the homicide rate among black males between 15 and 24 years of age, such as drug use, increased availability of firearms and increased child abuse were not, in fact, major determinants of the change in homicide rates.
- Published
- 1994
46. Social and physical factors in the referral of people with traumatic brain injuries to rehabilitation
- Author
-
J M, Wrigley, W C, Yoels, C R, Webb, and P R, Fine
- Subjects
Adult ,Male ,Trauma Severity Indices ,Socioeconomic Factors ,Brain Injuries ,Decision Making ,Humans ,Regression Analysis ,Female ,Glasgow Coma Scale ,Models, Theoretical ,Referral and Consultation ,Patient Discharge - Abstract
Using standardized data abstracted from a representative sample of hospitals in north-central Alabama, we analyze significant social and physical factors in acute care discharge referral patterns for 756 people with traumatic brain injury (TBI). When a Physical Medicine and Rehabilitation specialist is involved in the referral, patients receive more formal rehabilitation care following discharge, even after controlling for the relevant social and physical characteristics of the patient. Other significant variables predicting the level of rehabilitation care include presence of injury-related complications, abnormal computed tomography scan, longer length of acute care stay, being unmarried, older, and having an unintentional injury. Patients not seen by rehabilitation medicine specialists and/or those whose injuries provide less clinical evidence (implying greater uncertainty of diagnosis) are less likely to be referred to more formal rehabilitation. Thus, social and demographic factors may be significant in referral patterns when diagnostic uncertainty is present. Results suggest the importance of increasing availability of rehabilitation medicine consultation for TBI patients, while informing acute care providers about formal rehabilitation as a management option.
- Published
- 1994
47. P01-351 - A Review of Involuntary Admissions to a Psychiatry of Old Age Specialist Unit
- Author
-
M. Wrigley and Mary Davoren
- Subjects
medicine.medical_specialty ,Referral ,business.industry ,Mental Health Act ,Mental illness ,medicine.disease ,Unit (housing) ,Psychiatry and Mental health ,Long-term care ,Chart review ,medicine ,Etiology ,Dementia ,Psychiatry ,business - Abstract
ObjectivesIn this review we examined the involuntary admissions to a purpose-built Psychiatry of Old Age (POA) specialist unit under the care of the North Dublin Psychiatry Of Old Age Service, Dublin, Ireland.Our objectives were to examine the source of referral, progress in hospital and outcomes of all involuntary admissions, under the Irish Mental Health Act, to this Psychiatry of Old Age specialist inpatient unit over a one year period. All patients were divided into two groups, those who were diagnosed with Dementia and those patients who had a functional mental illness. We specifically examined the characteristics of both groups to identify any differences their outcomes.MethodsA retrospective chart review of all involuntary admissions over a one year period from January 1st 2008 to December 31st 2008 was conducted.Results67% of all admissions to the Psychiatry of Old Age unit during 2008 were involuntary admissions. The detained patients were mostly male (71.4%).The most common diagnoses were Alzheimer's Dementia (38.1%), Dementia Mixed Aetiology (14.3%) and Psychotic Illness (14.3%).88.2% of Patients who had a diagnosis of Dementia required Long Term Care at the end of their admission, but only 25% of those patients who had a Functional Mental Illness were transferred for Long Term Care at discharge.ConclusionsPatients with dementia had significantly longer involuntary admissions than patients with affective or psychotic disorders. Patients with dementia were also more likely to require long-term care on discharge than those patients who did not have dementia.
- Published
- 2010
- Full Text
- View/download PDF
48. Consultation-liaison referrals to the north Dublin old age psychiatry service
- Author
-
M, Wrigley and R, Loane
- Subjects
Aged, 80 and over ,Hospitals, Psychiatric ,Male ,Mental Disorders ,Humans ,Female ,Hospitals, General ,Ireland ,Referral and Consultation ,Aged - Abstract
107 elderly acute hospital in-patients were referred to the North Dublin Old Age Psychiatry Service during an eighteen month period. Cognitive impairment was present in 54%, 25% had functional psychiatric disorders and 19% had no psychiatric diagnosis. The main reason for referral in 47% of cases was advice on placement. This reflects the deficiency in residential care in North Dublin and supports other recently compiled data. The implications of this situation for both elderly people and the acute hospitals are discussed.
- Published
- 1991
49. A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas
- Author
-
M. L. Slevin, N. P. Deasy, R. C. Thuraisingham, P. F. M. Wrigley, Peter Johnson, Matthew T. Seymour, and P. I. Thompson
- Subjects
Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Leucovorin ,Adenocarcinoma ,Gastroenterology ,Folinic acid ,Bolus (medicine) ,Internal medicine ,Mucositis ,Medicine ,Neoplasm Metastasis ,Gastrointestinal Neoplasms ,Neoplasm Staging ,Chemotherapy ,business.industry ,Stomach ,medicine.disease ,Surgery ,Regimen ,medicine.anatomical_structure ,Oncology ,Fluorouracil ,Lymphatic Metastasis ,Toxicity ,business ,medicine.drug ,Research Article - Abstract
The combination of high-dose folinic acid with 5-fluorouracil has shown improved response rates in several trials in advanced colorectal carcinoma. This however is at the expense of increased toxicity: regimens using weekly bolus injections produce diarrhoea in most patients and occasional toxic deaths from this, whilst those using daily injections for one week in four report both diarrhoea and severe oral mucositis. Both types of regimen have significant rates of myelosuppression. A recent report described a different schedule of 5-fluorouracil and folinic acid, which appeared better tolerated but equally active (De Gramont et al., 1988). Here we report results using the same programme, in 64 patients with advanced adenocarcinomas. (Forty three colorectal, ten gastric, six pancreatic and five of unknown primary.) Patients received 200 mg m-2 folinic acid by infusion over 2 h followed by an IV bolus of 5-fluorouracil 400 mg m-2 then an infusion of 5-fluorouracil 400 mg m-2 over 22 h. This was repeated over the next 24 h. The schedule was given every 2 weeks for a total of six to 12 courses depending upon the response. The overall response rate was 26% in 62 evaluable patients. No toxicity greater than WHO Grade II occurred. Diarrhoea and mucositis did occur in around 10% of treatments but were not troublesome. No febrile neutropenic episodes were seen. Despite previous reports which described only modest activity for this combination against stomach cancers, this regimen demonstrates low toxicity but retains good activity in the palliative treatment of both gastric and colonic adenocarcinomas.
- Published
- 1991
50. Multivariate procedures to describe clinical staging of melanoma
- Author
-
K G, Manton, M A, Woodbury, J M, Wrigley, and H J, Cohen
- Subjects
Adult ,Male ,Skin Neoplasms ,Multivariate Analysis ,Humans ,Female ,Prospective Studies ,Middle Aged ,Melanoma ,Survival Analysis ,Algorithms ,Aged ,Neoplasm Staging - Abstract
Analyzing multivariate clinical data to identify subclasses of patients being treated for a specific disease may improve patient management and increase understanding of the behavior of disease under clinical conditions. In some cases, patients have been classified on prognostic characteristics using standard risk assessment procedures (e.g., Cox' regression). This requires long term follow-up, differentiates patients only on attributes relevant to survival, and assumes that patients are sampled from a common population. Other approaches involve the use of clustering algorithms to classify patients into categories based on multiple clinical attributes. We illustrate the use of a multivariate statistical procedure to directly characterize patients on multiple clinical characteristics. The procedure is designed to analyze discrete response data with parameters representing individual differences within groups. Its use is illustrated for patients with Stage I melanoma in determining how age is related to treatment response in different patient groups.
- Published
- 1991
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.